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Abstract 
Tracheostomised mechanically ventilated patients are often left unable to speak, which is 
frustrating for patients and the staff caring for them. Having no voice causes major distress 
and feelings of helplessness for patients. Voicelessness frequently leads to reduced 
information exchange between the patient and healthcare team, frequently to the detriment 
of patient care. An in-line speaking valve (SV) is a one-way valve that may be used in the 
mechanical ventilation circuit to enable verbal communication in tracheostomised patients. 
Limited data exist regarding the effect of SVs on respiratory mechanics. Deflation of the 
tracheostomy cuff is required for placement of the SV, effectively causing a “leak” in the 
ventilation circuit. Current bedside monitoring in intensive care unit (ICU) does not allow a 
clinician to observe what is happening in patients’ lungs during SV use. Concerns exist 
that this leak may cause lung derecruitment and atelectasis, delaying liberation from 
mechanical ventilation, thereby extending the patients’ length of stay in ICU. 
Patients can use alternative means of communication in ICU, including: pen and paper,
communication boards, gestures; and mouthing words silently. Numerous reports indicate 
that these methods are a poor substitute for verbal communication. Restoring verbal 
communication allows for dialogue between patient and ICU staff, ensuring more effective 
treatment. Restoring patients' ability to talk allows them to actively participate in their own 
care, potentially leading to increased cooperation and improvements to patients’ 
psychological welfare. However, data regarding the efficacy of SVs in improving
communication for the ICU patient are scant.
As an experienced speech pathologist, I believe concerns over SV use to date have little 
evidence. The main objective, and first aim of this thesis was to investigate the effect of SV 
use on respiratory mechanics to determine whether SVs should be used in-line with 
mechanical ventilation of tracheostomised patients. The second aim was to assess the 
effect of introducing SVs into a cardio-thoracic ICU on patient tracheostomy specific 
outcomes. The third aim was to further clarify the effect of SVs on success with health-
related communication for ICU patients. To achieve these aims, 5 studies were conducted, 
resulting in 5 manuscripts.
For the first aim, 20 tracheostomised ICU patients using a SV that met the inclusion criteria 
were recruited to the study from November 2013-December 2014. Electrical Impedance 
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Tomography (EIT) was used to assess the patients’ end-expiratory lung impedance (EELI)
and ventilation distribution continuously over 60 minutes (before, during and after SV use). 
Additional variables included oxygenation (SpO2), respiratory rate (RR), heart rate (HR), 
end-tidal carbon dioxide (EtCO2), ventilator data, ventilated surface area (VSA), and 
regional ventilation delay (RVD). Respiratory inductance plethysmography (RIP) was used 
to assess the respiratory muscle activity over the same time period. The results (Chapter 
3) show significantly increased EELI both during and post SV use. The data also indicate 
significantly decreased RR and EtCO2, with unchanged SpO2 and HR during SV use. 
Chapter 4 indicates a uniform increase of EELI across all lung sections, with no significant 
change in ventilation distribution. VSA and RVD findings are supportive of a potential 
recruitment effect of SVs. RIP data also presented in Chapter 4 suggest increased 
diaphragm activity during SV use. A case study presented in Chapter 5 highlights the 
need for clinicians to consider a patient’s underlying disease prior to SV use, with special 
caution required in relation to chronic obstructive pulmonary disease (COPD).
To achieve the second aim, data were collected for all tracheostomised patients across 
four consecutive years, prior to (2011) and following the introduction of an in-line SV 
(2012-2014) into a cardio-thoracic ICU. Data included: demographics; disease specifics 
and severity – acute physiology and chronic health evaluation (APACHE III) and 
sequential organ failure assessment scores (SOFA); ICU survival; tracheostomy and 
ventilation duration and specifics; timeframes and specifics of verbal communication and 
oral intake. Chapter 6 reports that patients returned to verbal communication 3 times faster 
during 2011-2014.  Seventy percent of tracheostomised patients used a SV on a ventilator 
in 2014 (compared to 0% in 2011). Other variables remained similar across the four years, 
with SVs having no impact on ventilator weaning and decannulation time.
For the third aim, 25 patients and 52 nursing staff were asked to fill out a custom-made 
questionnaire on success with health communication, firstly when the patients were 
voiceless, and, secondly, when they were using a SV. Chapter 7 highlights individual 
differences and some disparity between patient and nursing ratings of communication 
success. Overall, however, following SV use both the patients and nursing staff reported a 
significant improvement in success with health communication.
In conclusion, the findings of this thesis addressed the research aims, and provide new 
knowledge through use of an innovative approach to assessing lung mechanics. Having 
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already resulted in real clinical changes in our centre, the results indicate the potential for 
optimising communication, using SVs in tracheostomised cardiothoracic ICU patients 
undergoing weaning from mechanical ventilation. 
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1.0 Background and rationale
The liberation of long-term tracheostomised intensive care unit (ICU) patients from 
prolonged mechanical ventilation can be challenging and at a great cost to health care 
institutions [1-4]. Each year, more than 7000 patients receive tracheostomies in Australia 
and New Zealand. Many of these patients are initially ventilated in the ICU [5]. During the 
focus period of this thesis, 2010-2014, an average of 75 patients a year required a 
tracheostomy to facilitate liberation from prolonged ventilation at The Prince Charles 
Hospital (TPCH). Whilst being supported by mechanical ventilation, the tracheostomy cuff 
typically remains inflated to optimise ventilation. As a consequence, patients are left 
without the ability to use their voice, due to the loss of airflow via their upper airway (see
Figure 1-1 below). 
Figure 1-1: Tracheostomy in-situ. Cuff inflated, no air movement through the vocal folds
The traditional areas of focus in critical care medicine are physiology and physical well-
being, with psychological health frequently receiving limited attention. In-line speaking 
valves have the potential to facilitate verbal communication in patients ventilated via 
tracheostomy, but their use is often limited in this population due the lack of research 
regarding their efficacy and concerns regarding their risk of impairing ventilation. As the 
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3cuff around the tracheostomy tube needs to be deflated for the placement of the speaking 
valve (SV), a ‘leak’ is created in the ventilation circuit, often thought to cause loss of lung 
volume, and potential collapse of the alveoli (derecruitment). Collapse of lung tissue can 
exacerbate respiratory compromise and impede or reverse the weaning process. 
However, there are no data examining the changes in lung volume or ventilation 
redistribution, which may occur in cuff deflation with or without a SV in-situ. Until recently, 
there has been no technology which could safely and simply assess these parameters.
Whilst there are other methods of communication that patients can use (e.g., mouthing;
communication boards; pen and paper) to attempt to overcome the absence of their voice, 
current evidence indicates that patients rate verbal communication as the only means of 
communication that is highly successful [6]. Patients have associated the inability to 
verbally communicate with social withdrawal, leading to depression, lack of motivation to 
participate in care [7-10], poor sleep, and increased anxiety and stress levels [11]. 
Patients’ inability to communicate their needs to clinical staff leads to decreased exchange 
of vital diagnostic information, decreased adherence to recommendations, and poor 
patient satisfaction with the healthcare service [12]. To date there are no published data 
comparing the perceived success with health communication from the perspectives of both 
patient and nursing staff. Assumptions are often made that the message conveyed by a 
patient has been understood by staff. Communication occurs on a reciprocal basis (it is a 
"two way street"), however, there have been no studies to analyse the perception of 
communication from both equally important participants.
This thesis incorporates work completed on a cohort of tracheostomised mechanically 
ventilated cardio-thoracic ICU patients, in order to investigate SV use in a novel way, with 
a view to improving the patient journey and clinical outcomes. 
1.1 Aims
The aims of this PhD are:
1. To investigate the effect of SV use on the respiratory mechanics of 
tracheostomised ICU patients weaning from mechanical ventilation;
2. To assess the effect of introduction of SVs into a cardio-thoracic ICU on patient 
tracheostomy specific outcomes;
3. To clarify the effect of SVs on success with health-related communication for 
tracheostomised ICU patients weaning from mechanical ventilation.
41.2 Hypotheses
To test these hypotheses the following studies were performed:
For first aim
1. In order to determine the effect of SVs on EELVs, a prospective observational study 
was conducted with 20 patients. Electrical impedance tomography (EIT) was used 
to assess lung mechanics in real time before, during and after SV use in patients 
weaning from mechanical ventilation (Chapter 3).
2. To determine the region across which the increase of lung volume occurred, EIT 
data were analysed to assess ventilation distribution across four regions of interest 
(ROI) in the lung in the same group of 20 patients noted above (Chapter 4).
3. An opportunistic research case is reported in Chapter 5. This is a single case study 
of a patient with chronic obstructive pulmonary disease (COPD) in whom SV use 
created respiratory compromise.
For second aim (Chapter 6)
4. Tracheostomy and Speech Pathology (SP) specific outcomes for all 
tracheostomised patients across four consecutive years (pre- and post- introduction 
or SVs) were analysed to determine the potential effects of the introduction of SVs 
into routine clinical practice. 
For third aim (Chapter 7)
For first aim:
1. Use of SVs in tracheostomised patients weaning from mechanical ventilation
causes an increase in end-expiratory lung volumes (EELV).
2. SV use in tracheostomised patients weaning from mechanical ventilation causes 
a redistribution of ventilation into different parts of the lung.
For second aim:
3. Routine SV use in a cardio-thoracic ICU does not have a deleterious effect on 
tracheostomy specific outcomes for patients.
4. Routine SV use in a cardio-thoracic ICU results in tracheostomised patients 
regaining verbal communication earlier.
For third aim:
5. SV use results in increased success with patients’ health-related communication 
reported by both the patients and nursing staff.
55. Success with health-related communication was measured using a purpose-
designed visual analogue scale before and during SV use on patients (n=20) and 
their nurses (n=52). 
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This chapter provides an overview of communication options in ventilated tracheostomised 
patients and provides information regarding respiratory physiology. The first part of the 
chapter gives a basic overview of tracheostomies (section 2.0); it then discusses the main 
options for restoring patients' voice and outlines potential concerns with using these 
options, and suitability of these for ICU patients (section 2.1). In the second part of the 
chapter a detailed overview of the respiratory system is given, which underpins verbal 
communication (section 2.2). The role of the upper airway in respiratory process, and 
imaging options for the respiratory system, are also discussed in this section. The chapter 
concludes with a more detailed overview of other communication options and their
importance in the critically ill, tracheostomised patient population (section 2.3).
2.0 Tracheostomy
A tracheostomy is a common procedure in a complex intensive care environment. A 
tracheostomy tube (TT) is inserted into more than 7000 patients across Australia and New 
Zealand each year [13]. A tracheostomy is an artificial opening made into the trachea 
through the neck, either surgically in the operating theatre or, these days much more 
commonly, percutaneously in the ICU. A TT is inserted through the artificial opening and
enables airflow to enter the trachea and lungs directly, bypassing the nose, pharynx and 
larynx (see Figure 1-1 in Chapter 1). The opening is aimed to enter the trachea around the 
gap between the second and third tracheal rings [14]. An endotracheal tube (a tube into 
the airway through the patient’s mouth) usually precedes the TT in ICU. The endotracheal 
tube (ETT) is often replaced with a TT when the need for an alternative airway is seen to 
persist for longer, (i.e., in relation to patients needing prolonged mechanical ventilation). 
There is an ongoing debate in medical literature around the optimal time to perform a 
tracheostomy [15, 16], as any new procedure brings with it risks. When intubated with an 
ETT, patients are often sedated for tube tolerance [17, 18] since it usually causes 
considerable discomfort. Prolonged sedation, however, can result in other complications
(e.g., increased critical illness polyneuromyopathy and delirium [19]). Once TT is 
performed, the patients are often more comfortable [20, 21], require less analgesics and 
sedative agents, and may be able to return to activities such as eating/drinking, sitting out 
of bed [22], walking and talking.
There are different types of TTs that are used for different purposes (e.g., different length 
or width of the tube; tubes with or without a cuff; tubes with a suction port, fenestrated 
8tubes etc.). In the cardio-thoracic ICU where the studies for this thesis took place, most 
tracheostomised patients receive their tracheostomy due to a need for prolonged 
ventilation. In such cases, the preferred tube is a cuffed TT. The cuff is essentially a 
balloon around the tracheostomy tube inside the trachea that can be inflated or deflated. If 
inflated, it is most commonly filled with air. For patients on mechanical ventilation, the cuff 
is inflated to create a closed respiratory circuit, leaving no air leak towards the upper 
airway. This means that inhaled and exhaled air travels directly to the lower airways and 
back through the TT, thereby completely bypassing the upper airway. As a result, usual 
laryngeal/pharyngeal and nasal functions such as voice, cough, taste, smell, and swallow
are limited. The patients, when asked, are often distressed about not being able to 
communicate during this critical time in their lives [8, 23, 24].
2.1 Communication with a tracheostomy tube
Communication is said to be a basic human right. It is a daily activity that develops at a 
young age and from this time forward we take the ability to communicate as a given, never 
thinking about the impact of losing this ability on our lives. It is only in situations where 
communication is lacking or not possible that we realise its importance. One situation 
where normal communication ability may be lost, or substantially changed, is in critically ill 
tracheostomised and mechanically ventilated ICU patients. Once an ICU patient is 
conscious it can be frustrating for the patient, staff and family when communication is 
difficult and limited. Moreover, communication difficulties during hospitalisation pose a 
significant risk factor for preventable adverse events [25]. The two more commonly 
discussed options for verbal communication in this population are "leak speech" and SV 
use. 
2.1.1 Leak Speech
Leak speech is a term used to describe voice production during a period of cuff deflation. 
The cuff around the TT is deflated and, in most cases, some airflow through the upper 
airway is restored, with the potential for phonation to occur (see Figure 2-1 below).
9Figure 2-1: Tracheostomy in-situ. Cuff deflated, air movement through the vocal folds and 
back into tracheostomy tube (leak speech enabled)
Hoit et al [26] have described leak speech use in mechanically ventilated patients with 
spinal cord injury and neuromuscular disease. Their research has shown that lengthening 
the inspiratory phase and increasing positive end-expiratory pressure (PEEP) in the 
ventilatory settings resulted in improved speech production for their patients, with no 
subsequent respiratory compromise. MacBean [27] compared leak speech, addition of 
PEEP to leak speech, and use of SVs in a patient with spinal cord injury. They found that 
leak speech alone is not as successful as adding PEEP to leak speech or using a SV. 
Supplementing a patient’s ventilation with PEEP during weaning can be dangerous, 
therefore this is not often a feasible option in the ICU. The cohort described in the two 
studies noted above is long-term ventilated patients with spinal cord injury, therefore 
differing to acute ICU patients with a ventilator weaning plan.
2.1.2 Speaking valves
SVs are one-way valves that can be used in tracheostomised patients to restore expiratory 
airflow through the upper airway, thereby facilitating functional use of the glottis/vocal folds 
(see Figure 2-2 below). 
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Figure 2-2: Tracheostomy in-situ. Cuff deflated, SV in-line with ventilator tubing. Exhalation 
through the vocal folds only.
There are a number of different SVs available. All SVs allow inhalation via the 
tracheostomy cannula, but exhalation is redirected around the tracheostomy cannula out 
through the upper airway. Most SVs cannot be used in-line with a mechanical ventilation 
circuit. There are closed and open position SVs. SVs that are used in-line with mechanical 
ventilation circuit are generally closed position SVs, such as the SV shown on Figure 2-2. 
A closed position SV means that inspiratory flow is needed to open the diaphragm of the 
valve for inspiration. The diaphragm then closes at the end of inspiration once inspiratory 
flow is minimal. That keeps a column of air inside the TT. All of the exhalation is then 
redirected around the deflated cuff towards the vocal folds, with no air able to flow back to 
the TT [28]. An open position SV has a diaphragm in an open position, meaning that 
expiratory flow is needed to close the diaphragm. As a consequence the first part of 
expiratory air has to travel through the TT and close the diaphragm of the SV, leaving the 
rest of expiratory air to flow through the upper airway. This often results in patients 
coughing secretions into the TT and partially blocking the open-position SV.
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The use of SVs with a cuffed TT first requires the cuff to be fully deflated to create a path 
for expiration via the upper airway. SVs, like TTs, can have an impact on respiration 
depending on their design and characteristics. Studies investigating different SVs [28-30]
found that SVs varied significantly in terms of their aerodynamic characteristics, including 
in relation to their impact on airway resistance, work of breathing (WOB), and timing of 
closure of the SV diaphragm for expiration. In conclusion, the authors recommended that 
these characteristics should be considered when choosing a SV, with reference made to 
the underlying condition of the patient. 
A valve reported to have mid-range airway resistance and WOB implications, with no leak 
volume or closure delay between the beginning of expiration and closure of the valve [28-
30], was deemed most appropriate for the cardio-thoracic ICU population investigated in 
this thesis. Independently, this SV (PMV007, Passy Muir Inc, California, USA) has been 
found to produce the best speech quality, as reported by listeners and participants [31].
2.1.3 Concerns about SVs and leak speech
Leak speech and SVs are the most sustainable options for verbal communication in 
tracheostomised patients that are mechanically ventilated. Both of the options require 
deflation of the tracheostomy cuff. The role of the cuff around the TT in mechanically 
ventilated patients is to create a closed circuit of ventilation. Deflation of this cuff creates a 
leak in the ventilator system, meaning some of the gas meant to enter the lungs exits via 
the upper airway. In these circumstances less gas enters the lungs and it has been 
suggested this could cause derecruitment in the patients’ lungs. 
No studies reporting on lung physiology of critically ill patients with acute respiratory 
disease using leak speech or SVs have been published. However, our research group
assumed that fully restoring the patient’s glottic function with a SV, thereby potentially 
restoring the patients’ physiological PEEP, is better than just partially enabling it with leak 
speech. Anecdotally, concerns have also been raised about the recommendation to 
increase PEEP for leak speech in critically ill patients weaning from mechanical ventilation. 
It is not known whether adequate ventilation and perfusion during leak speech is 
guaranteed when following the above-mentioned modifications that improved leak speech 
in chronically ventilated patients [26]. 
Some suggestions about changes in the ventilator settings to better accommodate a SV 
have been offered. For instance, Passy-Muir™ suggests increasing tidal volume (TV) in 
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volume controlled ventilation modes until the peak inspiratory pressures (PIP) match those 
prior to cuff deflation, and turning off ventilator delivered PEEP, as physiologic PEEP is 
restored with the SV [32]. However, it is only possible to increase the TVs of mandatory 
breaths. The majority of patients in Australian ICUs, when using a SV in-line with a 
ventilator, are breathing spontaneously and frequently in pressure support ventilation
(PSV) mode. Therefore, such ventilator modifications are often not feasible to compensate 
for the leak in the circuit. More research is needed to inform best practice of mechanical 
ventilation for successful SV use. In order to understand how deflation of the cuff and SVs 
may cause changes in respiratory mechanics, however, it is first necessary to understand 
the physiology of breathing.
2.2 Respiration
Adequate respiration is essential for successful verbal communication in a healthy person. 
Good airflow is needed to produce voice, regardless of the presence of a TT. In a 
tracheostomised mechanically ventilated patient, the ventilator can usually compensate for 
what is lacking in a compromised respiratory system and successful voice production can 
still be achieved with a SV. The following sections give an overview of anatomy of the 
respiratory system and the basic physiology of breathing, to better understand the 
potential effect of cuff deflation and SV use on lung mechanics.
2.2.1 Anatomy of the respiratory system
Respiratory structures can be divided into the upper and lower airways. The upper airway 
consists of the nose, mouth, pharynx and larynx. When a person has a tracheostomy for 
ventilation purposes, the upper airway does not take part in respiration, having been ‘cut 
off’ by the inflated tracheostomy cuff (see Figure 1-1 on page 2). The lower airways still 
actively take part in respiration when a cuffed tracheostomy is in-situ. The lower airways 
include: trachea; bronchi; bronchioles; terminal bronchioles (known as the conducting 
zone) and respiratory bronchioles; alveolar ducts and alveolar sacs where gas exchange 
occurs (known as the respiratory zone) [33] (see Figure 2-3 below). At the distal end of
trachea, the airway divides 23 times, terminating in an estimated 30000 pulmonary acini.
Each pulmonary acini contains more than 10000 alveoli. An individual may have between
270 million to 790 million alveoli, the number depending on the height of that individual
and total lung volume. At the end of expiration (functional residual capacity) their diameter 
is 0.2mm. From here onwards gas exchange occurs through the alveolar septa [34]. 
Oxygen is delivered to, and carbon dioxide adsorbed from, pulmonary circulation. 
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Ventilation (gas movement) occurs throughout the respiratory structures. As mentioned 
above, perfusion and gas exchange take place in the lower airway. Alveoli need to be kept 
open and perfusion guaranteed around the alveoli for adequate gas exchange to occur.
The area where ventilation occurs but no perfusion takes place is known as anatomic dead 
space (with this area including all of the upper airways and conducting zone). The 
anatomic dead space in a patient with a tracheostomy is significantly shortened, due to 
exclusion of the supraglottic area.
																																																		 																																
																																																																																		
Figure 2-3 [35]: Anatomy of upper and lower airways (image on left custom-made by  
Cognuse; image on right used with permission from Dr.Rode)
2.2.2 Importance of the upper airway in respiration process
There is limited knowledge regarding the specific role and function of upper airways in the 
ventilation/perfusion process. In normal breathing patterns it is established that nasal 
breathing is typical. This has several major advantages over mouth breathing – e.g., 
filtration by the vibrissae hairs, humidification and warming of the inspired gas [34]. None 
of these can occur when breathing via a cuffed TT. Ventilation via a TT limits or removes
any role/function the upper airways have in the ventilation and/or perfusion process. In this 
context, however, cuff deflation and SV use has the potential to partially restore the 
function of upper airways.
There is limited research investigating the role of glottis as intra-abdominal pressure and 
intra-thoracic pressure regulator [36, 37], or in the quality of postural control/balance [38]. 
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Pressures in the abdomen and thorax are affected by the glottis, and glottal function varies 
between tasks such as talking, breathing and coughing. Massery [38] found that partial 
opening of the glottis, such as when counting out loud, resulted in best postural control. 
Research has also linked breath-holding (glottal closure) as a natural response to heavy 
loads [39]. England [40] found that vocal fold movements influence the pattern of 
breathing. The larynx is capable of withstanding pharyngeal pressures as high as 80kPa 
(600mmHg) which may be generated during swallowing [34]. In patients that are
tracheostomised and mechanically ventilated, all pressures are regulated by the positive 
pressure coming from the ventilator rather than the usual negative pressure ventilation in a 
healthy person. Accordingly, the upper airway has little to no role in coordinating intra-
abdominal and intra-thoracic pressure in these patients.
Conceptualisation of the respiratory system as a whole from glottis at the top down to the 
pelvic floor has been described as a "soda pop can model" [41]. Whenever the system has 
a ‘leak’ due to stress, incontinence or an open TT, the whole system’s pressure regulation 
is altered. With a cuffed TT in-situ, and ventilation occurring mechanically via the 
ventilator, the function of the upper airway is not utilised, as mentioned above. Once again, 
however, by deflating the cuff and using a SV this could potentially be restored, at least 
partially.
Clinicians are primarily interested in assessing the resistance of the intrathoracic (lower) 
airways [42] rather than the upper airway and its role in respiration. The ventilator can be 
set to deliver PEEP which assists in splinting the alveoli open in a patient with a TT. There 
are a number of factors that keep the alveoli open in a healthy person. Key amongst these 
would be unadsorbable nitrogen (N2), surfactant, and upper airway resistance. The upper 
airway is responsible for physiological PEEP [40]. The ventilator is unable to mimic the 
variability of physiological PEEP caused by the opening and closing of the glottis 
throughout the respiratory cycle and tasks such as talking and coughing. Hyatt [42] found 
that there is large variability in upper airway resistance between participants. The upper 
airway was found to normally account for approximately 45% of the combined airway 
resistance (expiratory + inspiratory). By contrast, it accounted for 20% resistance in 
emphysematous participants, with the difference in resistance attributable to resistance in 
the lower airways only. Resistance in the lower airways is far greater in cases of 
obstructive airway disease. Given these considerations, caution needs to be taken when 
additional resistance from the larynx is added by deflating the cuff and using a SV in 
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patients with obstructive lung disease. Hyatt [42] also found that upper airway resistance 
decreased with increasing lung volumes. Ferris et al [43] reported that nasal breathing 
increased upper airway resistance significantly. Hyatt [42] found that most of the upper 
airway flow resistance (i.e., PEEP) during mouth breathing occurs in the larynx. If the vocal 
folds move into complete adduction, airway resistance becomes infinite. This also explains 
the variable physiologic PEEP.
The use of the upper airways in tracheostomised patients during expiration may be 
facilitated by the use of a SV in the ventilator circuit, which requires deflation of the TT cuff 
(see Figure 2-1 on page 9). This, however, may cause an air leak towards the upper 
airways during inspiration, unless the patient is strong enough to close their glottis for 
inspiration. Hence, inadequate inspiratory gas delivery to the alveolus for adequate gas 
exchange could induce hypoxemia and hypercarbia. At the same time, the restored 
physiological PEEP provided by the upper airways with the deflated tracheostomy cuff 
may facilitate persistent alveolar opening, more than compensating for the ‘leaking air’ in 
the anatomic dead space. Also, the restoration of some negative pressure ventilation by 
deflating the cuff and using the SV may have an impact on cardiac output and perfusion. 
There have been no published studies looking at the impact of cuff deflation and SV on 
lung mechanics or perfusion, which has significantly limited the use of SVs with patients in 
ICU. 
2.2.3 Measurement of ventilation
Usual bedside monitoring equipment is limited to monitoring the patients’ oxygen 
saturation (SpO2), respiratory rate (RR), and WOB to ensure their ventilation is adequate 
when a SV is in-situ. Even TVs and pressure data are not accurately displayed on the 
ventilator once the SV is in-line with the ventilator circuit as there is no expiration back 
towards the ventilator. Once the SV is removed, these data, including end-tidal carbon 
dioxide (EtCO2), can once again be assessed.  Usual bedside monitoring equipment does 
not enable monitoring of EELV or regional ventilation and ventilation distribution in the 
lungs. As a consequence, it is impossible to know whether derecruitment or hyperinflation 
of some parts of the lungs occur when making any changes to the ventilator set-up 
(including the SV) without further imaging.
The conventional means to monitor ventilation is with computed tomography (CT). This is
expensive, exposes the patient to radiation and often requires the ICU patient to be 
sedated and transferred to the medical imaging department. The transfer of patients adds 
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risks to patient care, including the possibility of equipment failure due to less monitored 
environment during transportation, as well as potential exposure of patients to infection 
risk [44, 45]. The need for sedation makes CT less suitable if its purpose is to see potential 
changes in a fully conscious patient (such as someone using a SV). To be able to assess 
any changes before, during and after an intervention would require serial imaging, which in 
the case of CT would entail exposing patients to more radiation. 
Chest x-rays that are commonly used in ICU are not precise enough to visualise any 
changes: this technique only captures one brief moment in breathing cycle. A tool gaining 
popularity – lung ultrasound [46, 47] - has not been proven to be precise enough to detect 
the changes anticipated with SV use.  In addition, it can only cover a small part of the lung 
at a time. Another relatively novel technique for imaging the respiratory system is Electrical 
Impedance Tomography (EIT), the subject of detailed discussion below.
2.2.3.1 Electrical Impedance Tomography
EIT is a non-invasive, radiation free, real-time bedside imaging equipment that allows for 
continuous monitoring of ventilation distribution and end-expiratory lung impedance
(EELI). EELI has been shown to be highly correlated with EELV or functional residual 
capacity (FRC) [48-50].
EIT involves placing a belt equipped with 16 electrodes around the circumference of the 
patient’s chest at intercostal space 5-6. Small electrical currents are sent through each of 
the 16 electrodes and the voltage is then read by all electrodes, creating 208 potentials per 
image (see Figure 2-4 below). Impedance is measured and translated to gas in the lungs,
generating a real time moving image of air in different parts of the lung on a computer 
screen. Impedance means resistance, and resistance to electrical currents moving 
through the patient’s chest varies depending on the amount of gas present in their lungs. 
As lung volumes change throughout inspiration and expiration, this translates to varying 
impedance throughout the respiratory cycle.
EIT data is highly dependent on the belt position, and only captures data from the segment 
of lung where the EIT belt is situated [51, 52]. Therefore the images do not necessarily 
detect ventilation changes in the whole lung.
EIT can be used to identify and assess changes in EELI and ventilation distribution over 
time (i.e. before, during and after SV use). EIT can measure changes in EELI only as long 
as the electrode belt is kept around the patient’s chest. Upon removal and replacement of 
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the belt, a new baseline is calculated, therefore EELI results are not comparable to those
previously measured [48, 53-55], meaning that prolonged monitoring is difficult in a clinical 
setting.
Figure 2-4: Electrode placement and current injections with EIT (used with permission from 
Professor John Fraser)
It is known that patients receiving positive pressure ventilation shift their ventilation 
distribution towards ventral parts of the lungs [56, 57]. Being supine in bed may also be a 
contributor to this ventral shift in ventilation. Such shifts can be seen with using EIT. It is 
not known whether cuff deflation and SV would cause any shift in ventilation distribution. 
2.2.4 Muscles of respiration
Positive pressure ventilation delivered from the ventilator differs from the natural negative 
pressure ventilation that we all experience when breathing spontaneously. This is where 
the muscles of respiration play a vital role.
There are other structures outside the airways that have a vital role in respiration, most of 
which take part in inspiration (the active phase of breathing). Several muscle groups are 
involved in breathing. Muscles of the pharynx and larynx control upper airway resistance. 
The diaphragm, ribcage, spine and neck muscles bring about inspiration. Muscles of the 
abdominal wall, ribcage and spine are used when active expiration is required. While
respiratory muscles are discrete, it must be remembered that they act almost 
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harmoniously rather than as separate muscles in isolation. This extraordinarily complex 
interaction is influenced by factors including posture, minute volume, respiratory load, 
disease and anaesthesia [58]. 
The most important muscle of inspiration is the diaphragm, a membranous muscle 
separating the abdominal cavity and chest. In adults it has a total surface area of about 
900 cm2 [58]. During normal breathing the diaphragm moves about 1cm, but on forced 
inspiration and expiration a total excursion of up to 10cm may occur. A healthy diaphragm 
moves down during inspiration to force the abdominal contents downward and forward, 
thus increasing the vertical dimension of the chest cavity. When the diaphragm is 
paralysed, it moves up rather than down during inspiration because the intrathoracic 
pressure falls [33]. It is recognised that diaphragm weakness develops rapidly with 
mechanical ventilation, which can lead to prolonged liberation from ventilatory support. 
Studies have shown that disuse atrophy in the diaphragm develops as quickly as 18hrs on 
controlled mechanical ventilation [59]. This is due to positive pressure ventilation use, 
during which the diaphragm has no active role, as opposed to normal respiration, when
negative intrapleural pressures exist.                             
The external intercostal muscles contract during inspiration and pull the ribs upward and 
forward, increasing the diameter of the thorax in lateral and anteroposterior aspects. The 
accessory muscles of inspiration include the scalene muscles. There is minimal activity in 
these muscles during quiet breathing but during exercise they may contract vigorously. 
Other muscles that play a role include the alae nasi, which cause flaring of the nostrils, 
and small muscles in the head and neck [33], including the vocal folds which control upper 
airway resistance by abducting to minimise resistance on inspiration and adduct slightly to 
increase resistance during expiration. This may help prevent collapse of the lower airways 
[58]. The alae nasi and vocal folds do not take part in respiration when a patient is 
breathing through a cuffed TT.
In healthy lungs expiration is usually passive. It is only during voluntary hyperventilation 
and exercise that expiration becomes active in a healthy person. The most important 
muscles of expiration are those of the abdominal wall, including the rectus abdominis, 
internal and external oblique muscles, and transversus abdominis. When these muscles 
contract, intra-abdominal pressure is raised and the diaphragm is pushed upward [33]. 
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These muscles, and the vocal folds, also contract forcefully during coughing, vomiting, and 
defecation. 
There have been a number of studies investigating the relative contribution of the ribcage 
and abdomen to lung volume displacement during quiet breathing and different speech 
tasks. Mandros et al [60] found that the pattern of chest wall configuration during quiet 
breathing largely predicts the pattern of ribcage and abdomen displacement during 
speech. Hixon [61] stated that the relative contribution of the ribcage and abdomen may 
vary among healthy individuals, and further found with Hoit [62] that in individuals with 
different body structure the pattern of ribcage and abdominal displacement for resting 
breathing was not predictive of the pattern of chest wall motion for speech production. To
date, no such data have been reported on mechanically ventilated ICU patients with 
potential diaphragm weakness. 
2.2.5 Measurement of respiratory muscle activity: 
There are several relatively accurate ways to measure diaphragm activity. One of these is 
using neutrally adjusted ventilatory assist (NAVA) probes to measure the electrical activity 
of the diaphragm [63-66]. This method was not considered an appropriate technique for 
use in this PhD due to it being costly and invasive in nature. 
Measuring esophageal pressure and gastric pressure is another way of assessing 
diaphragm strength. Most commonly this method involves using a nasogastric feeding 
tube with balloon(s) attached to the far end of the tube. The feeding tube needs to be 
connected to a pressure transducer to calculate transdiaphragmatic pressure (esophageal 
pressure minus gastric pressure), which is a specific measure of diaphragm activity [67]. 
This method was not considered for use in this PhD due to lack of such equipment, funds 
and specialist knowledge around issues with catheter positioning and validation. 
Another method of measuring respiratory muscle activity, diaphragm ultrasound, is quickly 
gaining popularity [68-70]. This technique was not considered appropriate for use in this 
PhD since there is little to no immediate effect on muscle fiber thickness anticipated with 
SV use that diaphragm ultrasound could identify and visualise.
Though not the most accurate way to measure diaphragm activity, respiratory inductance 
plethysmography (RIP) was chosen as the most suitable tool to use in conjunction with EIT 
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to assess ribcage and abdominal mobility and thereby gain a better understanding of the
effect of a SV on diaphragm activity for the purpose of this PhD.
2.2.5.1 Respiratory Inductance Plethysmography
RIP is a validated technique to assess abdominal activity and, in this case, the potential 
effect of SV on chest and / or abdominal displacement during respiration. It is a non-
invasive respiratory monitoring technique that quantifies changes in the cross-sectional 
area of the chest wall and the abdominal compartment. The technique uses two elastic 
bands that contain wires attached to the bands in a zigzag form. One is placed around the 
patient’s chest, 3cm above the xiphoid process, and the second is placed around the 
abdomen (see Figure 2-5 below). Each of these bands produces an independent signal 
and the sum of these two signals is calibrated against a known gas volume [71]. TVs and 
abdominal-to-chest ratio (A:C ratio) can be calculated based on extent to which the belts 
stretch during breathing. For the purposes of this thesis, only A:C ratios were calculated, 
and not the TV, due to difficulties measuring TVs in spontaneously breathing 
tracheostomised patients with an expiratory leak. 
Figure 2-5: EIT and RIP set-up on a tracheostomised mechanically ventilated ICU patient 
(with patient permission)
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In terms of measuring A:C ratios, it is assumed that increased abdominal mobility would 
suggest increased diaphragm activity. However, due to the complexity of the muscular 
system involved in breathing, the changes in the A:C ratio cannot be attributed to changes 
in the force of contraction in any particular muscle [58]. Therefore the change in the 
abdominal mobility is an estimated change in diaphragm activity. RIP can be used to 
monitor changes over time, for example before, during and after the SV use.
This chapter has considered and described the two most common ways of restoring verbal 
communication in critically ill tracheostomised patients still requiring support from a
ventilator. An overview of respiratory mechanics and ways to measure it has also been 
presented. It is demonstrably the case that patient communication is important, especially 
in the critical care environment. Restoring the patients’ own voice is not always possible 
due to various reasons. The next section in this chapter gives an overview of all other 
communication options for these patients, most of which are commonly used due to 
concerns over cuff deflation and SV use. 
2.3 Communication
Communication can be categorised in multiple different ways. For successful verbal 
communication one needs both speech and language. Language is the content and 
meaning of what we are saying. Speech is the execution of those thoughts into sounds 
and words. Essential components of speech are respiration, phonation, resonance and 
articulation [72]. 
There are language centres in the brain that are responsible for comprehension and 
expression of thoughts. These language centres translate thoughts into words and 
sentences that are produced verbally as a result of signals sent to the muscles that are 
responsible for speech production. In ICU a patient’s ability to communicate may be limited 
due to either a neurological disruption that prevents or impedes the formulation of words 
and sentences, or else a physical or structural problem (e.g., a breathing tube) that 
deprives the patient of the use of their voice. Where an ICU admission is due to a 
neurological event, the patient’s speech and/or language centres may be affected, causing
communication impairment. In cardio-thoracic ICU patients, a primary neurological basis to 
communication disability is less likely. Basic speech and language abilities are generally 
intact, with the patients’ level of alertness often sufficient for communication.
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Communication is often challenging when ICU patients are tracheostomised and 
mechanically ventilated. Respiration for these patients takes place through the TT below 
their vocal folds, rendering patients voiceless due to the temporary change in the anatomy 
of their upper airway (as discussed above; see also Figure 1-1 on page 2). As verbal 
communication is often not possible for these patients, other modes of communication 
need to be used. All modes of communication other than natural speech are often referred 
to as augmentative and alternative communication (AAC), which can include both verbal 
and non-verbal modes of communication. 
2.3.1 Non-verbal communication
Non-verbal communication is utilised by people on a daily basis to accompany and 
augment verbal communication (such as gesture, facial expression, drawing). Reliance 
solely on non-verbal modes of communication can present challenges to both the 
“communicator” and communication partners, limiting the success/effectiveness of 
conveying the intended message. 
With any type of non-verbal communication difficulties start with gaining the attention of a 
prospective communication partner to initiate ‘conversation’. In a usual communicative 
situation we can gain attention verbally, although the same result can be achieved using
other sources of noise (e.g., clapping hands, tapping foot etc.). Initiating conversation is 
especially difficult for patients in a noisy ICU environment, where they often have restricted 
limb movement and no voice when tracheostomised and mechanically ventilated. There is 
limited research assessing communication initiation of ICU patients. Lasiter [73] reported 
on “The Button” (i.e., the nurse call light), which participants found somewhat helpful in 
getting the help they needed. 
One of the most common modes of communication attempted by non-verbal patients in 
ICU is mouthing and gesture. It is attempted by most tracheostomised mechanically 
ventilated patients in ICU at some stage and success is highly dependent on the patient’s 
oromusculature ability, level of alertness and also the communication partner’s ability to 
lip-read. It is often frustrating for both parties and makes it difficult for the patients’ 
thoughts to be understood. Freeman-Sanderson reports an increase in patients’ ability to 
be understood by others as soon as patients have the ability to verbally communicate [74]
instead of mouthing their message. 
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AAC devices are a common option used for communication in the ICU. These can be 
divided into low-tech and hi-tech devices, with the latter being able to convey longer and 
more complex messages and offer a voice output option also (with this option considered 
a method of verbal communication). Some AAC systems are picture based while some are 
word-based, with the preferred system dependent on individual patient needs. Most 
devices come with pre-set messages; to know what they are able to "talk about", a patient 
will first need to be familiarised with what is on the board/booklet. There are specific 
communication boards that have been developed for ICU patients [75]. Patients that had 
experienced ICU stay and mechanical ventilation were consulted during the creation of the 
Vidatak communication boards to ensure that all the needs of a typical ventilated patient 
could be met. 
Non-verbal communication in an ICU environment often has both content and physical 
limitations. Most AAC devices require intact vision and some require the ability to learn 
new things, as successful use requires training of communication partners as well as the 
patient. AAC devices are often limited to word or phrase levels, potentially making the 
message less specific or accurate. Additionally, introducing fomites in the form of 
communication devices and boards into ICU can generate issues around infection control. 
In terms of content limitations, non-verbal communication is often focused on conveying 
basic needs rather than conversation since the methods employed are usually time 
consuming and lack accuracy. Pen and paper would allow for more precise messages to 
be communicated, however physical limitations such as level of alertness, upper limb 
strength and mobility restrictions make this option difficult for ICU patients. There are 
different access options that can be used with AAC devices depending on limb dexterity –
from complex keyboards to a joystick. Eye gaze access is an option for patients with very 
limited or no limb mobility, with patients able to use their eyes instead of limbs to point to 
messages. Eye gaze access has been reported to be somewhat successful in patients 
with spinal cord injuries that have no limb movement but who are able to purposefully track 
with eyes [76]. Eye gaze access is slow and requires extensive training and is therefore 
often not suitable for all ICU patients.
Notwithstanding the potential availability of alternate modes of communication, patients 
strongly prefer verbal communication and it guarantees better success in conveying a 
message to the healthcare team and family [6].
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2.3.2 Verbal communication 
When patients were asked to reflect on and rate different modes of communication, they 
reported verbal communication as the most successful mode of communication. Pen and 
paper were rated as moderately successful, and mouthing and gesture were rated with a 
low success rate [6]. Commonly we associate verbal communication with an individual 
using their own voice, however devices such as voice output applications and 
electrolarynx can be included as forms of verbal communication. 
2.3.2.1 Electronic voice options for communication
An increasing number of voice output devices are available, ranging from those that use 
preset recordings of a spoken word or a whole message at the press of a button through to 
“type to speak” applications on smart phones and tablets. Their biggest advantage over 
non-verbal communication is being heard. Most of the high-tech AACs again require the 
user to have good fine-motor skills, learn the steps of the application and work to 
individualise the content, which makes use of these devices in the ICU environment 
challenging.
The electrolarynx has been successfully used as a verbal communication option for some 
tracheostomised patients [77], although it is primarily designed for laryngectomised 
patients that have no other means of producing voice. It requires the speaker to have the 
vibrating head (sound source) of the electrolarynx placed against their neck or cheek and 
use clear articulation to mouth their message. The downsides of the electrolarynx are 
numerous: patients have to learn a new skill; patients need to have excellent 
oromusculature movement for intelligible articulation; good fine-motor skills are required to 
be able to hold the electrolarynx in a suitable spot on the neck or cheek; the voice is 
‘mechanical’, not produced using the vocal folds, and therefore it is not the patient’s own 
actual voice. An electrolarynx could be a feasible communication option for some long 
term or permanently tracheostomised patients but is not considered a viable option for 
most ICU patients.
2.3.2.2 Natural voice options for verbal communication
Verbal communication options that use the tracheostomised patient’s own voice all involve 
some form of modification to the TT or to the way in which it is used with or without a 
ventilator. Modifications or alterations to the tracheostomy set-up include: SVs; leak 
speech with or without ventilator adjustments; above cuff vocalisation; TTs with a special 
inner cannula with a SV; cuffless TTs; capping/corking, and finger occlusion. McGrath [78], 
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whilst concentrating on above cuff vocalisation, describes some of the other 
communication options available for TT patients in ICU. Not all of these options can be 
used with tracheostomised patients that are mechanically ventilated. 
2.3.2.2.1 Verbal communication options for non-ventilated tracheostomised patients 
only
Table 2-1 – Verbal communication options for tracheostomised patients
Applicable to 
mechanically ventilated 
tracheostomy patient
Applicable to ventilated 
and non-ventilated 
tracheostomy patients
Above cuff vocalisation Yes Yes
Special TTs (i.e. Blom TT) Yes Yes
Leak speech Yes Yes
Speaking valve Yes Yes
Finger occlusion No Yes
Capping / corking No Yes
Cuffless TTs Sometimes Yes
Finger occlusion can be used to test for patients’ ability to breathe around the deflated 
tracheostomy cuff or for momentary voicing. Whilst longer periods of voice production
could be trialed with finger occlusion, this method is not feasible for prolonged 
communication in ICU as someone needs to hold their finger in front of the tracheostomy 
cannula at all times during phonation. This is difficult for the patients to coordinate with 
potentially poor upper limb function and could therefore also create an infection risk. In the 
ICU environment finger occlusion is often used as a diagnostic intervention to assess 
whether a patient is a suitable candidate for a SV. This method can only be used with 
patients that can tolerate a period of time off mechanical ventilation [79]. 
Instead of finger occlusion, capping/corking is sometimes used to occlude the 
tracheostomy cannula. Although its efficacy is not evidenced in literature, it is still used as 
a step towards decannulation in some countries. It involves deflating the tracheostomy cuff 
and covering the TT with a cap, so that all inhalation and exhalation occurs via the upper 
airway. Hussey at al [80] reported that the pressures required for the patient to breathe 
around a deflated cuff far exceed the pressures in a normal native human airway (i.e., size 
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8 TT required more than 20 cmH2O at all flows higher than 20 L/min). Unless the TT is 
size 4 in an adult trachea, this method should not be used. 
Verbal communication is sometimes successful with a cuffless TT. Cuffless TTs are often 
used in the paediatric population; they are generally used in adults only if there is no need 
for mechanical ventilation and airway protection. Though there are reports in the literature 
[81] that the vast majority of tracheostomised patients with severe respiratory insufficiency 
and reasonably competent oropharyngeal muscles can be safely and adequately 
ventilated up to 24h a day with their cuffs deflated or removed, this is not done in the 
Australian ICU environment. As ventilators used in ICUs do not usually cope with leaks in 
the ventilatory circuit, it is not a feasible option for ICU patients. In addition, no studies 
have reported on the impact of using cuffless tubes in liberating critically ill patients from 
mechanical ventilation.
2.3.2.2.2 Verbal communication options suitable for non-ventilated and 
mechanically ventilated tracheostomised patients
The use of a patient’s own voice for communication in the mechanically ventilated 
tracheostomised population can be achieved by modifying or altering the ventilator and 
tracheostomy set-up. This includes above cuff vocalisation, special TTs, leak speech, and 
SV. 
Some TTs are designed with above the cuff suction lines that enable ‘above cuff 
vocalisation’ when gas-flow is connected to the suction-line port. The suction line has an 
opening above the cuff to help remove secretions from this area, which has shown to 
decrease risk of ventilator associated pneumonia (VAP) [82]. Besides being able to keep 
the area clean from secretions and potential colonising bacteria, gas-flow can be 
connected to the above the cuff suction-aid tubing to enable airflow through the upper 
airway and vocal folds despite the inflated cuff. This method has shown some success in 
tracheostomised patients. Leder [10] suggests that 10-15L/min of airflow produces 
intelligible speech with minimal patient discomfort. McGrath [78] has also reported on a 
few recent ICU cases where above the cuff vocalisation was successfully employed. 
However limited data exist on the effectiveness of functional use of the vocal folds with this 
technique. The drying effect, including the potential for laryngeal injury of continuous non-
humidified air running through the glottis, is also a potential problem area with above cuff 
vocalisation [83].
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Another option is a special fenestrated TT that comes with a speech cannula and two 
valves that can be used for patients to phonate with an inflated cuff. Inspiratory pressure 
opens the flap valve and closes the bubble valve, sealing the fenestration so that all of the 
inspired air goes to the lungs. As inspiration ends, the flap closes. Expiratory air collapses 
the bubble valve, which unblocks the fenestration and directs all of the exhaled air to the 
upper airway for phonation [84]. Kunduk et al [85] reported that this speech cannula was 
safe, effective and well tolerated while maintaining cuff inflation. The use of this method 
requires a TT change, as these special tubes are not usually the first choice of tubes upon 
tracheostomy insertion. There is limited literature exploring the use of these tubes in the 
ICU population, indicating these tubes are not suitable for patients weaning from 
mechanical ventilation [86].
There is also a special TT that has a cuff which only deflates on expiration, allowing for 
partial expiratory flow to bypass the tracheostomy cannula and exit via the upper airway. 
This type of tube, if successful, allows TT patients to talk without any modifications needed 
to the TT [87]. The use of leak speech and SV also fit in this category (see sections 2.1.1 
and 2.1.2 for specifications).
2.3.2 Communication in ICU
With so many different communication options available for a tracheostomised ICU patient, 
it takes specialist knowledge to choose the most suitable option for each patient. A recent 
systematic review attempted to present a flowchart to guide the clinician with decision 
making around the best communication option for such patients [88], however this 
flowchart fails to emphasise the importance of verbal communication. Speech pathologists 
are widely acknowledged to be key members of the multidisciplinary team helping
tracheostomised patients with communication in ICU [89]. Early SP intervention for these 
patients has been shown to result in less time taken for tracheostomised patients to return 
to verbal communication [90]. 
A significant proportion of patients have limited communication abilities during most of their 
ICU stay; their inability to communicate effectively can have both short- and long-term 
impact. Communication has been identified as one of the key areas of frustration for 
patients in ICU [8, 23, 24]. A recent study [74] reports increased satisfaction and quality of 
life for tracheostomised ICU patients once able to verbally communicate using a SV. 
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Anecdotal observations and informal reports from clinical staff suggest that the presence 
of confusion/delirium is easier to establish when patients are talking. It is also easier to re-
orientate and reassure the patient when they are able to verbally respond. There is no 
published literature determining the role of early verbal communication in ICU, nor its 
impact on the development and duration of delirium. Anecdotal evidence also suggests 
that enabling early verbal communication in tracheostomised patients can lead to patients 
being able to better report on their previous and current health condition, which has the 
potential to result in better use of healthcare expenditure. 
A significant volume of published literature exists around the importance of communication 
in the ICU environment. There are studies that examine how patients and ICU physicians, 
nursing staff, and families perceive communicative interactions. There are also many 
studies looking at staff communication during clinical handover practices and delivery of 
care [91-95]. All of these studies report the importance of communication from all parties to 
warrant best patient care.
Despite this emphasis on communication, less has been reported around patients’ 
success with communication in ICU. Very few published studies provide a comparison 
between patient and staff perceptions of communication success in the ICU when the 
patient is tracheostomised. There is one study [96] exploring the perceived difficulty of 
communication in ICU with ventilated patients in which both multidisciplinary staff and 
previously ventilated patients were asked to rate the level of difficulty with communication. 
Not surprisingly, the study found that patients reported a higher level of difficulty in 
communicating as compared to staff. As tracheostomised and mechanically ventilated 
patients have a 1:1 nurse to patient ratio in Australian ICUs, this is a critical relationship to 
study. Nurses spend the most time with patients, therefore their ability to understand the 
patient is critical. A study by Leathart [97] found that nurses’ interactions with a ventilated
ICU patient on average lasted less than 30 seconds. This is clearly not enough time for a 
patient to successfully convey their message. Nursing staff have found that verbal 
communication makes it easier for them to look after patients [8, 97, 98].
2.4 Conclusions of literature review
This chapter has highlighted the importance of verbal communication in the critically ill 
tracheostomised ICU patient population. SV use was identified as being the best method 
for restoring verbal communication for these patients, as it “normalises” physiology during 
exhalation and enables use of patients’ own natural voice. The unfounded concerns over 
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the SV’s potential negative effect on respiratory mechanics, and best ways to measure 
these mechanics were introduced in this chapter. These concerns have stopped SVs from 
being routinely used in ICU population, and therefore needed exploring.
This PhD thesis, through innovative research studies presented in the next 5 chapters, 
provides answers to the following questions: does a SV increase EELV? (Chapter 3); does 
it cause a shift in ventilation distribution? (Chapters 4 and 5); is it safe to use SVs on 
patients that are still mechanically ventilated? (Chapters 3 and 4); how does SV impact 
diaphragm activity? (Chapter 4); does routine SV use effect tracheostomy and ventilation 
specific ICU outcomes for patients? (Chapter 6); does a SV improve the patient’s success 
with health related communication? (Chapter 7). 
A summary of the thesis findings, limitations and areas for future research are included in 
Chapter 8.
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Chapter 3 Speaking valves in tracheostomised ICU patients - weaning off 
mechanical ventilation – do they facilitate lung recruitment?
3.0 Rationale and significance
It was established in Chapter 2 that patients prefer to be able to communicate verbally: 
one way to achieve this outcome is through the use of a SV. This chapter focuses on the 
effect of SVs on the patients’ EELVs and bedside respiratory parameters. The specific SV 
used in this study is a Passy Muir SV (PMV007, Passy Muir Inc., California, USA).
To recap, concerns have been raised in the past regarding patient lung physiology and 
recovery if SVs are used; related primarily to the risk of lung derecruitment. There are no 
published data to support these concerns, with no detailed information available as to what 
happens to the lungs when a TT cuff is deflated with or without a SV. The insertion of a 
SV, which allows leakage of expiratory gas, dramatically diminishes the data available to 
the clinician from the ventilator. There is no way to monitor the patients’ lung volumes or 
obtain other data on expiration with routinely available clinical bedside techniques due to 
the absence of expiratory flow back into the ventilator. It is therefore essential to rigorously 
examine the effect of the SV on regional ventilation within the patients’ lungs to determine 
whether or not SV use entails the risks outlined above. As transporting patients to 
radiology for CT is expensive and comes with increased risk [44, 45], this was not an 
option. EIT, being a relatively new real-time radiation free bedside imaging tool [99-102], 
was found to be ideal in answering this key clinical question of whether patients’ lungs are 
compromised when using SVs. 
To address the main aim of this thesis, this study was designed to monitor patients’ lung 
mechanics before, during and after SV use through examining the following key variables: 
(1) EELI; (2) RR; (3) heart rate; (4) SpO2; (5) EtCO2, and ventilator data, including: (1) 
PEEP; (2) PS; (3) PIP, and (4) TV. Prior to this study, this analysis had never been 
attempted. 
The results of this study have been presented in over 25 international, national and local 
invited conferences and lectures, as highlighted in Presentations during candidature on 
page vii. Best Novice Clinical Presentation Award was gained at the TPCH Research 
Forum in November 2016 following presentation of this study. This chapter was published 
in Critical Care in 2016. Sections, tables and figures have been renumbered, abbreviations 
continued and formatting changed according to the style of Journal of Critical Care to align 
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with the rest of the thesis document. References to ‘open lung strategy’ and ‘work of 
breathing’ have been removed from the Introduction and Discussion sections in the 
manuscript below.
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Speaking valves in tracheostomised ICU patients weaning off mechanical 
ventilation – do they facilitate lung recruitment?
Sutt A-L, Caruana LR, Dunster KR, Cornwell PL, Anstey CM, Fraser JF
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3.1 Abstract 
Introduction
Patients who require positive pressure ventilation through a tracheostomy are unable to 
phonate due to the inflated tracheostomy cuff. Whilst a SV can be used on a TT, its use in 
ventilated ICU patients has been inhibited by concerns regarding potential deleterious 
effects to recovering lungs. The objective of this study was to assess EELI and standard 
bedside respiratory parameters before, during and after SV use of tracheostomised 
patients weaning from mechanical ventilation. 
Methods
A prospective observational study was conducted in a cardio-thoracic adult ICU. 20 
consecutive tracheostomised patients weaning from mechanical ventilation and using a SV 
were recruited. EIT was used to monitor patients’ EELI. Changes in lung impedance and 
standard bedside respiratory data were analysed pre, during and post SV use. 
Results
Use of in-line SVs resulted in significant increase of EELI. This effect grew and was 
maintained for at least 15 minutes after removal of the SV (p<0.001). EtCO2 showed a 
significant drop during SV use (p=0.01) whilst SpO2 remained unchanged. RR decreased 
whilst the SV was in-situ (p<0.001), and HR was unchanged. All results were similar 
regardless of the patients’ respiratory requirements at time of recruitment.
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Conclusions
In this cohort of critically ill ventilated patients, SVs did not cause derecruitment of the 
lungs when used in the ventilator weaning period. Deflating the tracheostomy cuff and 
restoring the airflow via the upper airway with a one-way valve may facilitate lung 
recruitment during and after SV use, as indicated by increased EELI. 
3.2 Introduction
Invasively ventilated patients are unable to phonate due to either the ETT positioning 
through the vocal folds, or when ventilating through tracheostomy, the air bypassing the 
vocal folds. SVs can be used in-line with mechanical ventilation, but use of these requires 
deflation of the tracheostomy cuff [103]. Cuff deflation causes a leak in the ventilator 
circuit, which has been considered detrimental to patients’ ventilation, and potentially 
deleterious to weaning.   
The key concern raised by physicians is that by deflating the cuff, and thus losing PEEP 
this could lead to loss of lung volume through alveolar collapse. It has been demonstrated
that loss of PEEP in other events, such as suctioning [71, 104] and ventilator 
disconnection [105], causes loss of lung volume. Hence, practices that may cause loss of 
lung volume must be used with some degree of caution.
One small case series has described the apparently safe use of SVs during weaning from 
mechanical ventilation [106]. Another study found no significant difference in ventilator 
weaning and decannulation times post the introduction of in-line SVs into an adult ICU 
[107, 108]. Whilst these studies provide preliminary clinical support for use of in-line SVs 
with tracheostomised mechanically ventilated patients, there are no physiological data to 
prove or allay fears. 
Currently there are no data regarding the effect of SVs on EELV, a critical point when the 
lungs are at most risk of collapsing. A SV is a one-way valve that allows for inspiration via 
the TT whilst expiration is redirected to the upper airway via the vocal folds enabling 
phonation [103] and restored upper airway resistance. Hence it can be considered 
functionally as a PEEP valve on the tracheostomy. As there is no airflow back into the 
ventilator tubing with the one-way valve, current in-situ monitoring of ventilation with 
standard bedside equipment provides the clinician with limited information regarding 
ventilation. While computerised tomography may be able to provide this information, the 
repeated use of these imaging procedures could be seen as ethically unjustifiable, 
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expensive, may require a level of sedation and put patients at risk with the transfer outside 
of the ICU environment [44, 45]. 
EIT is a radiation-free real time bedside imaging tool capable of measuring the air 
movement in and out of the thorax [99-102]. It has been observed as being a safe, reliable 
and reproducible technique to assess regional ventilation in the lung, specifically during 
recruitment manoeuvres [71]. In the future it may be possible for absolute EIT to directly 
measure EELV but current time-differencing systems rely on measuring the difference 
between end-inspiratory lung impedance and EELI to measure tidal variation of impedance 
and changes in EELI [100]. A linear correlation exists between changes in the EELI and 
changes in EELV [48, 50, 109], although this relationship tends to over-estimate changes 
in EELV [109]. A limitation of time differencing EIT is that it is unable to detect the pre-
existing EELI [53, 54] which means it can only detect changes in EELI if the device 
remains in-situ and running between readings [48, 53-55]. Researchers, however, have 
successfully used EIT to detect changes in EELI due to various clinical interventions such 
as suctioning, position change, and changes in PEEP [55, 101, 109-112]. 
This study aimed to assess the effect of SVs on EELI. Based on the findings of prior case 
studies it was hypothesised that there is an increase in global EELI with the SV in-situ 
when patients are performing trials off the ventilator (i.e. on 50L of 40% oxygen via 
tracheostomy). This may potentially be similar when patients are constantly supported by 
mechanical ventilation, given restored physiological PEEP. Secondary aims included 
determining the effects of SV on patients’ RR, HR, SpO2 and EtCO2. The potential effect of 
talking versus quietly breathing with SV in-situ on respiratory mechanics and the effects of 
SV and its dependence on the patients’ ventilatory requirements at the time were also 
investigated.
3.3 Methods 
Following human ethics approval by the Institutional Review Board (HREC/13/QPCH/95) a 
prospective observational study (ACTRN12615000589583) using a repeated measures 
design was conducted. The study took place in a primarily cardio-thoracic ICU at a 
metropolitan tertiary teaching hospital. Consecutive patients tracheostomised and 
undertaking weaning from mechanical ventilation from November 2013 to December 2014 
were considered for inclusion in the study if they were tolerating a SV for a minimum of 30 
minutes, as jointly assessed by a speech pathologist and a physician. Patients were 
excluded if they had significant language or cognitive deficits, or were not suitable to wear 
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an EIT belt (i.e. patients with ventricular assist devices, open chest, extensive sternal 
dressings/drains or dependent on cardiac pacing). Twenty patients were recruited in 2 
groups: 1) 10 on PSV, and 2) 10 patients having trial periods off mechanical ventilation 
(and transferred onto high flow or low flow oxygen via tracheostomy). All patients provided 
written informed consent, or, for those unable to sign consent was provided by a legally 
authorised person (e.g. family member) or by the patient’s nurse witnessing verbal 
consent. The study was conducted in accordance with the ethical standards laid down in 
the 1964 Declaration of Helsinki.
3.3.1 Measures
Following informed consent, patients were enrolled in the study. EIT (Pulmovista, Draeger 
Medical, Lubeck, Germany) measurements were taken continuously for 60 minutes with 
the frame rate set to 10Hz to give EELI per breath.  Transitions to and from SV were 
followed by 15-minute periods, to allow for stabilisation [113]. 
Set ventilator delivered PEEP and FiO2 data were collected from the ventilator (Puritan 
Bennett 840, Covidien, Dublin, Ireland). HR and SpO2 were measured with pulse oximeter 
(504, Criticare systems, Wisconsin, USA).  Airway pressure (Paw) was measured directly 
via a neonatal feeding catheter (6F). This was introduced through the Luer port of an 
adaptor (Ikaria, New Jersey, USA) advanced to lie just distal to the tracheostomy cannula 
in the trachea, and measured with a pressure transducer (PPT, Honeywell, New Jersey, 
USA). Oximeter and pressure data were collected at 200Hz (PowerLab, ADInstruments, 
Sydney). EtCO2 was sampled from the feeding tube and measured (Marquette Solar 8000, 
GE Healthcare, Little Chalfont, UK). EtCO2 was measured continuously throughout the 60
minutes apart from 2 minutes before, during and after SV use when continuous Paw
measurements were taken through the same catheter. There was no flow through the 
catheter during pressure measurements to ensure highest possible fidelity. All data were 
collected on a breath-to-breath basis using custom written software.
3.3.2 Procedure
The patients were positioned either in bed at 45 degrees or in a straight backed chair with 
the EIT electrode belt around their chest at the level of the 5th to 6th anterior intercostal 
space. As patient position has been shown to have an impact on ventilation distribution
[101], we ensured that there were no significant changes in patient positioning throughout 
the data collection. A neonatal feeding catheter was inserted as described above and the 
pulse oximeter was positioned on the finger.
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Fifteen minutes of data were recorded continuously during four discrete periods: (1) 
baseline – prior to placement of the SV in-line with mechanical ventilation; (2) quiet 
breathing with SV in-line; (3) talking with SV in-line, and (4) post removal of the in-line SV. 
After the baseline period the tracheostomy cuff was deflated with simultaneous tracheal 
suctioning to clear secretions pooling above the cuff and minimise aspiration. The SV 
(PMV007, Passy Muir Inc., California, USA) was then inserted in-line with the ventilation 
circuit following the adapter that accommodated the EtCO2/ Paw catheter. Ventilator 
settings were changed while the SV was in-situ in the patients supported by PSV. This 
included switching the system to non-invasive (NIV) mode for PSV (to more easily control 
expiratory alarms) and reducing the set ventilator delivered PEEP by 5cmH2O [32]. This 
change in settings was based, in the absence of any scientific data to define optimal 
settings, on recommendations by the SV manufacturer. During the second data collection 
period patients were instructed to continue to breathe normally and avoid talking. Once 
data collection period 3 commenced the patients were instructed to converse as they 
wished with the researcher, family member, or healthcare team. In the case where verbal 
communication was limited, the researcher used picture cards and open-ended questions 
to facilitate verbal output. As there is a suggested difference in breathing patterns between 
different speech tasks (planned vs. non-planned) [114], no set tasks were given to 
participants, instead, spontaneous speech was encouraged. At the completion of period 3, 
the ventilator settings were returned to baseline, SV was removed, and the tracheostomy 
cuff re-inflated. Data collection continued in period 4 as per baseline conditions. Routine 
tracheal suctioning was performed during data collection as per individual patient needs.
3.3.3 Data analysis
Data were analysed offline following data collection using commercially available Draeger 
software (Draeger EIT Data Analysis Tool 6.1). EELI was averaged across the readings 
and displayed as mean EELI for each of the 4 data collection periods. To investigate the 
changes in EELI compared to baseline a mixed effects regression model was used. 
Planned comparisons between baseline and each subsequent data collection period were 
conducted using paired t-tests for RR, EtCO2, HR and SpO2.  
The level of significance was set at p < 0.05 throughout with 95% confidence intervals 
quoted where appropriate. All statistical analyses were conducted using STATATM (version 
12.0).
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3.4 Results
During the study period 55 tracheostomised patients used a SV and were assessed for 
inclusion in the study. Of these patients, 20 met the inclusion criteria and were enrolled in 
the study.  Figure 3-1 below details the reasons for exclusion or non-participation in the 
study.
Figure 3-1: Participant selection chart
BiVAD – biventricular assist device; EIT – electrical impedance tomography; LVAD – left ventricular assist 
device; PMSV – Passy-Muir Speaking Valve; PPM – permanent pace maker
The mean age of the patients in the study was 60.4±14.9 years (50% male). The mean
age for all tracheostomised patients in the ICU throughout the recruitment period was 
57.1±17.4 years (64.6% male). On average patients used a SV for 2.5 days prior to 
recruitment to the study. Ten patients were assessed whilst being ventilated with PSV, and 
10 were assessed during periods off the ventilator (9 on high flow, one on low flow oxygen) 
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for the duration of data collection. All but one patient assessed off ventilator were still 
requiring >12 hrs/day of mechanical ventilation. See Table 3-1 below for the specifics of 
respiratory requirements. 
Table 3-1 – Participant ventilation needs
Pt No.
Vent. 
needs
a
Weaned
Y/N PS PEEP FiO2 Flow
1 HFTP N N/A N/A 40% 40L
2 HFTP Y N/A N/A 40% 40L
3 LFTP N N/A N/A 30% 5L
4 HFTP N N/A N/A 40% 50L
5 PSV N 10 5 40% N/A
6 HFTP N N/A N/A 40% 50L
7 HFTP N N/A N/A 40% 40L
8 PSV N 15 10 35% N/A
9 HFTP N N/A N/A 50% 50L
10 PSV N 13 10 40% N/A
11 HFTP N N/A N/A 40% 40L
12 PSV N 10 7.5 40% N/A
13 PSV N 15 5 35% N/A
14 HFTP N N/A N/A 30% 30L
15 HFTP N N/A N/A 40% 40L
16 PSV N 10 8 40% N/A
17 PSV N 10 5 35% N/A
18 PSV N 12 5 40% N/A
19 PSV N 12 8 45% N/A
20 PSV N 12 7.5 40% N/A
a 
respiratory needs at point of recruitment. Considered not weaned if needed mechanical ventilation in the 
preceding 24hours
FiO2 – fraction of inspired oxygen; Flow – O2 flow requirements at point of recruitment; HFTP – high flow 
tracheostomy piece (>30L/min of O2); LFTP – low flow tracheostomy piece (<30L/min of O2); PEEP –
positive end expiratory pressure; PS – pressure support; PSV – pressure support ventilation
The majority of patients (17) had their TTs inserted percutaneously in the ICU.  Primary 
reasons for ICU admission included cardiac surgery (n=13, 65%) or respiratory disease 
(n=5). Nineteen of the patients (95%) had received a tracheostomy due to prolonged need 
for mechanical ventilation. Patient number 3 had the tracheostomy initially inserted for 
surgery in the upper airway, but required prolonged respiratory support following cardiac 
surgery. See Table 3-2 below for more detailed description of all patients in the study.
Table 3-2 – Demographics and tracheostomy data
Pt No. Age Gender
Primary reason 
for ICU
# days TT to 
SV
# days to 
decannulation
Insertion 
method TT type and size
# days of SV use 
when recruited
1 63 M
acute myocardial 
infarct; CABG 11 18 perc
long flange Portex 
8 2
2 48 F
acute myocardial 
infarct; 
tamponade 5 12 perc cuffed Portex 8 6
3 72 F
Buccal SCC + 
CABG 5 7 surg cuffed Portex 7 0
4 71 M
tissue AVR for 
infective 
endocarditis 2 4 perc cuffed Portex 8 1
5 29 M endarterectomy 2 5 perc cuffed Portex 8 1
6 77 M
CABG x3 and 
mechanical AVR 6 23 perc cuffed Portex 8 1
7 44 F aortic dissection 6 7 perc cuffed Portex 8 1
8 33 F endarterectomy 4 12 perc cuffed Portex 7 4
9 61 M H1N1, ARDS 12 23 perc cuffed Portex 8 8
10 70 M CABGx2 3 5 perc cuffed Portex 8 1
11 70 F
cardiac 
tamponade 4 6 perc cuffed Portex 7 1
12 43 F PE 2 5 perc cuffed Portex 7 2
13 47 F Influenza A ARDS 4 6 perc cuffed Portex 8 1
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Pt No. Age Gender
Primary reason 
for ICU
# days TT to 
SV
# days to 
decannulation
Insertion 
method TT type and size
# days of SV use 
when recruited
14 70 F CAP 2 7 perc cuffed Portex 8 5
15 58 M CAP 3 N/A surg cuffed Portex 8 1
16 62 F CAP 2 6 perc cuffed Portex 8 1
17 74 F
extensive 
gastrointestinal
surgery 10 31 perc cuffed Portex 7 7
18 78 M CABG x4 3 5 perc cuffed Portex 8 2
19 60 M chest trauma 7 12 surg
long flange Portex 
8 2
20 77 M
re-do sternotomy 
for tissue AVR, 
CABGx1 4 13 perc cuffed Portex 8 2
ARDS – acute respiratory distress syndrome; AVR – aortic valve repair; CABG – coronary artery bypass graft; CAP – community acquired pneumonia; PE –
pulmonary embolism; perc – percutaneous; SCC – small cell carcinoma; surg – surgical; TT – tracheostomy tube; # - ‘number of…’
A statistically significant increase in EELI was observed between baseline and all 
subsequent data collection periods. A mean increase by 19.7% (213 units) occurred from 
baseline to period 2 (SV + quiet breathing, p=0.034). Further increase from baseline by 
83.6% (905 units) (p<0.001) and 120% (1299 units) (p<0.001) were seen in data collection 
period 3 and 4 respectively (see Figure 3-2 and Table 3-3 below). 
It is notable that patients’ ventilatory requirements at time of recruitment did not have a 
significant impact on change of EELI or change in any of the respiratory parameters or HR. 
The patients that were supported on PSV during data collection showed an initial non-
significant drop in EELI. However, a similar increase in EELI with patients off the ventilator 
was noted for the 3rd and 4th period of data collection (see Figure 3-2).
Figure 3-2: Mean EELI vs time with average EELI trend for non-vent and PSV
Mean EELI is plotted on the y-axis against a nominal timebase. A lowess smoothing line has been added to 
clarify the overall trend.
EELI – end expiratory lung impedance; non-vent – patient off mechanical ventilation during recruitment; PSV
– pressure support ventilation; SV – speaking valve 
EtCO2 showed a significant decrease during SV use (p=0.02 for period 2 and p=0.01 for 
period 3) and returned to baseline for period 4. RR showed a significant decrease from 
baseline while SV was used in-line with the ventilation circuit (p=0.001, p<0.001 for 
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periods 2 and 3 respectively), and returned to baseline once the SV was removed. HR and 
SpO2 showed no significant change throughout data collection. 
Table 3-3 – Outcome measures across 4 time periods
Baseline (1) SV (2) SV-talk (3) Post SV (4)
SpO2 96.5 (0.5) 95.5 (0.7) 94.7 (0.7) 96.0 (0.8)
RR 25 (1.6) 22 (1.5)* 20 (1.7)* 25 (1.4)
HR 95 (2.8) 95 (2.4) 96 (2.9) 96 (3.0)
EtCO2 29 (1.1) 27 (1.1)* 26 (1.2)* 28 (1.0)
Mean EELI 1082 (57) 1295 (61)* 1987 (60)* 2381 (75)*
All data are presented as mean (SEM)
* Statistically significant change, p<0.05
EtCO2 – end tidal carbon dioxide; HR – heart rate; mean EELI – mean end-expiratory lung impedance; RR –
respiratory rate; SpO2 – peripheral capillary oxygen saturation; SV – speaking valve
Only limited data on Paw were captured (3 participants with full data, 7 with partial data). 
These data all indicated similar drops in Paw, coinciding with the reduction of ventilator-
delivered PEEP for the duration of the SV use. Ventilator data showed minimal expired 
tidal volume when SV was in-line (see Table 3-4). 
Table 3-4 – Airway pressures (Paw), expired tidal volumes (TV) and peak inspiratory 
pressures (PIP)
Baseline (1) SV (2) Post SV (4)
Paw (n=7)
a
10.5cmH2O 5.6 cmH2O 10.7 cmH2O
TV (n=10)
b
0.550L 0.024L
c
0.534L
PIP (n=10)
b
19.8 15.1 20
a full data for all 3 periods from 3 patients only
b data from all 10 mechanically ventilated patients in the study
c two patients had higher TVs of 0.106L and 0.088L on average, and two patients had TVs of 0.0L
3.5 Discussion 
The findings indicated that use of SVs in this cohort did not result in any significant 
derecruitment of the lungs, contrary to the concerns initially voiced by physicians. 
Standard bedside monitoring demonstrated reduced respiratory rate with adequate gas 
exchange. The increase in EELI may indicate increased EELV. Further analysis is 
necessary to more fully determine ventilation distribution as an increase in EELV could be 
due to further recruitment or over-inflation of already aerated parts of the lung. 
The increase in EELI with the SV in the ventilator circuit is likely to occur through the 
restoration of the patient’s ability to breathe through the larynx and upper airway, as 
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opposed to the continuously patent TT. Upper airway resistance is increased due to the 
resistance created by exhalation against and around the effectively closed TT (through the 
actions of the SV) and its deflated cuff, ensuring more residual air in the lungs at the end 
of expiration. Further analysis is required to confirm that lung hyperinflation did not occur 
as it could be argued that an increase in EELI may correlate to tidal hyperinflation. We 
used SpO2 and EtCO2 as simple measures, to exclude pathological degrees of 
hyperinflation, but this cannot exclude it fully. Of note, all patients had been using a SV 
before the study with no gross signs of hyperinflation on routine chest x-ray. 
The subsequent increase in EELI seen when patients talked is explicable through the 
additional, but variable, upper airway resistance caused by the glottis [115], with vocal 
folds closing and opening during attempts at phonation. The SV appeared to act as a 
recruitment manoeuvre. An increase in EELI was observed during SV use and its effect 
remained after removal of the SV from the patients’ ventilation circuit. EELI remained 
stable for 8-9 minutes once the SV was removed from the ventilator circuit and the 
tracheostomy cuff re-inflated before further increase occurred. 
There are several potential explanations for the drop in EtCO2 during the SV use. One 
reason may be a drop in EtCO2 due to using one’s voice, as observed in a study done on 
healthy subjects [116]. Another potential reason is dead-space washout in the upper 
airway that has been found to coincide with an increase in tidal volumes in other studies
[117, 118]. With our current data, we cannot categorically state, however, that tidal 
volumes increased for patients in this study. A third potential aetiology may be that the 
exhaled air just past the tracheostomy cannula where EtCO2 was measured from was 
being diluted with fresh inspiratory flow in all patients on high flow oxygen, and some on 
PSV while the cuff was deflated. Transcutaneous carbon dioxide (TcCO2) and partial 
pressure of carbon dioxide in the arterial blood (PaCO2) may need to be measured in 
similar studies in the future.
Only limited data on Paw were captured. This was due to rapid and repeated obstruction of 
the fine bore catheter with secretions caused by the presence of no flow through the 
catheter during the several 2-minute measurements. A similar reduction in Paw coinciding 
with the turning down of the set ventilator-delivered PEEP for the duration of the SV use 
was noted. However, due to lack of data, it is difficult to draw any conclusions. Further 
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studies are needed to further look at Paw and ventilator delivered PEEP with and without a 
SV in circuit.
It was surprising to observe that the ventilator demonstrated substantial exhaled tidal 
volume whilst the SV was in-situ. This may indicate the presence of a leak in the SV or 
some form of back-pressure. This means that the ventilator may actually still be delivering 
PEEP when a one-way valve is in place, and will be the subject of further studies. 
Communication is a key issue for ventilated patients, who find the inability to speak 
distressing [8, 24, 119]. Difficulties with communication in the tracheostomised patient 
population have been associated with social withdrawal, leading to depression, lack of 
motivation to participate in care [7-10], poor sleep, and increased anxiety and stress levels 
[11] which has both short and long term impacts on patient outcomes in and post ICU. By 
demonstrating the potential physiological benefits on top of the already known and more 
obvious psychological benefits, SVs present an excellent way to improve patient care in 
the ICU. 
Increased use of SV raises various important questions. For instance, how long should the 
SVs be used for at any one time? Does this lead to fatigue? Should the SVs be used with 
patients during mobilisation? Future studies are needed to look at the efficacy of SVs in 
the weaning and rehabilitation process of mechanically ventilated tracheostomised ICU 
patients.
3.5.1 Limitations of the study
This study was conducted on a specific cohort of ICU patients, mostly cardiothoracic, and 
extrapolation of these data to patients with different pathologies may not be wise. This is 
even more relevant in patients with spinal and brain injuries where central control of 
breathing might be affected.
No patients in this study were ventilated using volume-controlled modes, hence there is a 
need to determine whether restored physiological PEEP through SV helps compensate for 
the leak in the ventilatory circuit similarly in volume-controlled ventilation.
Airway pressures were only measured for the second half of the study patients (n=10) with 
limited data obtained as described above. Hence the reported Paw data may be a poor 
representation of the actual Paw across the time points in the study and was therefore not 
reported in detail. Different methods to obtain this important data are recommended for 
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future similar studies. Minor difficulties also occurred with EtCO2 measurements 
(measured in all patients in the study) through the same catheter. However, the presence 
of airflow in the catheter during EtCO2 measurement reduced the likelihood of the catheter 
blocking with secretions, resulting in close to full data across 60 minutes obtained from all 
patients. 
Routine suctioning was performed as per patient needs throughout data collection. It is 
known that tracheal suctioning causes a degree of derecruitment [111]. The quantitative 
effect of suctioning was not specifically analysed as part of this study, nor were these 
periods excised from data analysis. Derecruitment caused by tracheal suctioning could 
therefore be a confounding factor and negatively skew our data on the effect of SVs.
The duration of the study was only a total of one hour, with SV in-situ for 30 minutes. 
Clinically the same patients would be using the SV for several hours at a time. Due to the 
inability to compare the change in EELI between sessions, and the patients needing to 
remain in the same position, the EIT belt stayed in-situ for the duration of the study with 
the patients sitting up. Therefore it was not feasible to monitor the patients for longer.
3.6 Conclusions
When SVs were used in this cohort of cardio-respiratory patients, we observed no 
evidence of lung derecruitment whilst weaning from mechanical ventilation. Deflation of the 
tracheostomy cuff with restoration of the airflow via the upper airway with a one-way valve 
facilitated an increase in EELI both during and after a period of SV use in our cohort of 
patients, which may indicate recruitment of the lungs. Use of the SV resulted in reduced 
RR and a reduced EtCO2.
47
Chapter 4
48
Chapter 4 The effect of SV on ventilation distribution, lung recruitment and 
diaphragm activity
4.0 Rationale and Significance
The results in Chapter 3 demonstrate that SV use causes a significant increase in EELI. 
However, this study did not assess the specific regionality in the changes of EELI. An 
increased EELI can mean either recruitment of lung tissue (potentially beneficial) or 
hyperinflation (definitely deleterious) in some areas of the lung. Therefore it could not be 
safely concluded that SVs are harmless to the patients’ lungs. To further expand on the 
main aim of this thesis, this next study analyses additional parameters using EIT 
technology to identify ventilation distribution. Updated software for use with our existing 
EIT device became available following our first publication (Chapter 3). It allowed analysis 
of (1) ventilated surface area (VSA) and (2) regional ventilation delay (RVD) investigating 
lung recruitment, alongside (3) distribution of EELI, and (4) tidal variation (TVar). These 
new techniques were therefore utilised to analyse data from before, during and after SV 
use to further determine the safety of SV use in cardiothoracic tracheostomised ICU 
patients weaning from mechanical ventilation.
Currently, there are few published studies that have examined such new modalities of EIT 
analysis on spontaneously breathing patients. Hence, being novel and innovative, as well 
as being able to assess for potential harm, it was felt an essential and logical addendum to 
the original question. There are no published guidelines on how to measure hyperinflation 
with EIT, especially with no access to pressure measurements. A potential method to 
interpret these new parameters to predict hyperinflation and/or recruitment, has been
included in the discussion section of this chapter to compliment the findings. 
Additionally, this chapter presents findings of a second study addressing the primary aim 
of this thesis. The importance of the diaphragm in breathing was established in Chapter 2. 
The significance of this muscle in breathing cannot be over-emphasised, therefore 
determining if a SV causes any adverse effect to the diaphragm is paramount. Data on 
A:C ratio using RIP techniques to predict diaphragm activity with and without SV are 
presented in section 4.2 of this chapter.
The results of these two studies have been presented in over 10 international, national and 
local invited conferences and lectures as highlighted in Presentations during candidature
on page vii. Presentation of the studies in chapter 3 and 4 led me to win the University of 
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QLD 3-minute-thesis (3MT) competition in September 2016. The first part (4.1) of this 
chapter was accepted for publication in Journal of Critical Care in April 2017. The results 
of the second part (4.2) of this chapter have been partially published in an abstract format
following ANZICS and ATS conferences. Sections, tables, figures and graphs across this 
chapter have been renumbered, and abbreviations continued to align with the rest of the 
thesis document. 
Changes from the manuscript in press with Journal of Critical Care:
In the original manuscript tidal variation was abbreviated as TV to align with previously 
published EIT literature. In the thesis document, the abbreviation for tidal variation has 
been changed to TVar to differentiate this from tidal volume (TV). Additional details have 
been added in the data analysis section. 
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4.1 Ventilation distribution and lung recruitment with speaking valve use in 
tracheostomised patient weaning from mechanical ventilation in intensive 
care
Sutt A-L, Anstey CM, Caruana LR, Cornwell PL, Fraser JF
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4.1.1 Abstract
Purpose
SVs are used infrequently in tracheostomised ICU patients due to concerns regarding their 
putative effect on lung recruitment. A recent study in cardio-thoracic population 
demonstrated increased end-expiratory lung volumes during and post SV use without 
examining if the increase in EELI resulted in alveolar recruitment or potential hyperinflation 
in discrete loci. 
Materials and Methods
A secondary analysis of EIT data from a previous study was conducted. EELI distribution 
and TVar were assessed with a previously validated tool. A new tool was used to 
investigate VSA and RVD as indicators of alveolar recruitment. 
Results 
The increase in EELI was found to be uniform with significant increase across all lung
sections (p<0.001). TVar showed an initial non-significant decrease (p=0.94) with 
subsequent increase significantly above baseline (p<0.001). VSA and RVD showed non-
significant changes during and post SV use.
Conclusions
In this study, hyperinflation did not occur with SV use, which is consistent with previous 
data. These data, along with obvious psychological benefits to patients are encouraging 
towards safe use of SVs in this critically ill cardio-thoracic patient population.
4.1.2 Introduction
SVs are not routinely used with tracheostomised patients while they still require 
mechanical ventilation in the ICU. These patients are generally left without a voice for 
prolonged periods due to concerns that the required cuff deflation could lead to alveolar 
collapse and derecruitment of the lungs. A recent study reported improved EELI when 
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using a SV in-line with mechanical ventilation [120]. Whilst increases in EELI may indicate 
alveolar recruitment, the analyses conducted to-date cannot exclude hyperinflation of 
some parts of the lung or in fact no clinically significant changes in lung volumes [54, 121]. 
Without analysing the distribution of EELI we do not know where this increase occurred, 
whether it was uniformly increased or only increased in dependent / non-dependent areas 
of the lung. The effect of increased EELI is important to determine as hyperinflation of the 
lungs could have a detrimental effect on patients’ lung recovery and weaning from 
mechanical ventilation. 
Currently several options exist to examine ventilation distribution using EIT data, thereby 
assessing lung recruitment in greater detail. Using TVar as one of EIT measures of 
ventilation distribution has been demonstrated by a number of studies [56, 122, 123] to 
provide valid information about the percentage of tidal volume in different parts of the lung. 
It is well known that mechanical ventilation (positive pressure) causes a shift in ventilation 
towards the ventral parts of the lungs [56, 124], which is more pronounced in the supine 
position. TVar can indicate whether similar shifts occur in a temporal manner. Changes 
such as a significant increase in EELI may have an impact on ventilation distribution.
Novel methods of estimating lung recruitment using EIT have recently been described in 
the literature [125, 126]. Two of these emerging EIT analyses to estimate changes in 
ventilation distribution and lung recruitment are VSA and RVD. In this study, VSA
represents the number of pixels in which the local impedance change is greater than a 
pre-determined percentage of the maximum of the local impedance change, calculating 
the VSA. It uses the ventilation distribution map to calculate the number of pixels within an 
EIT signal [126]. A higher value indicates a greater area of lung surface that is ventilated. 
RVD is a calculation of the delay between the global start of inspiration and the point in 
time where the regional impedance curve reaches a pre-determined impedance change (in 
this study 40%, as per Muders [127]). It gives data on delayed opening of lung areas that 
have been previously unopened or collapsed. Thus, alveolar recruitment can be detected 
by EIT and expressed as a simple index [123, 125]: the smaller the index, the smaller the 
delay. VSA and RVD calculations in this study slightly differ from these of Blankman [126]
as results are presented in pixel values, rather than percentage. 
Global inhomogeneity index (GI), a measure describing the homogeneity of lung 
ventilation, is also gaining more attention in EIT literature [128, 129]. However, this index 
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was not used for this study due to its difficulties in detecting hyperinflation and collapse of 
lung tissue.
These emerging methods for the analysis of EIT data are new and little has been reported 
on their significance and their correlation with lung disease and function. Together with 
previous methods of analysis such as EELI, EELI distribution and TVar there is the 
potential to obtain greater insights into how the previously observed increase in EELI 
during and post SV use [120] may impact lung recruitment and ventilation distribution.
The aim of this paper is to determine the ventilation re-distribution, if any, created by the 
increased EELI reported previously [120]. The secondary aim was to determine the 
efficacy of the novel EIT data analysis tool (EITdiagTM, Dräger Medical, Lűbeck, Germany) 
to further delineate the changes in alveolar recruitment. Due to the EITdiagTM software 
averaging raw data, this can result in loss of data fidelity and sensitivity prior to analysis. 
This may lead to difficulties in achieving statistical significance.
4.1.3 Material and methods
As none of the above-mentioned methods alone can give an absolute picture on the 
causes of increased EELI with SV use, a combination of these was decided to be the best
method. Variables designed for detection of hyperinflation and collapse of alveoli were 
chosen from published literature and combined with previously reported EELI analysis on 
the same data. VSA and RVD were analysed together with EELI distribution and TV to 
better understand the mechanism of the reported increase in EELI.
Data obtained from a previous study [120] underwent secondary analysis using EIT Data 
Analysis tool 6.1 (PulmoVista 500, Dräger Medical, Lűbeck, Germany) to assess EELI 
distribution and TVar into 4 ROIs. EITdiag™ was used to assess VSA and RVD globally 
and in 4 ROIs. Ethics approval was obtained from the local ethics committee 
(HREC/13/QPCH/95). Informed consent was granted by the patient or their legal 
representative.
4.1.3.1 Participants and Procedures
Data sets were obtained from twenty consecutive patients admitted to a cardiothoracic ICU 
in whom a SV (PMV007, Passy-Muir Inc, Irvine, California, US) was used in-line with 
mechanical ventilation and met the study inclusion criteria [120]. Two subgroups existed 
within the data set: (1) 10 patients receiving PSV using a PB840 (Puritan 
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Bennett/Covidien, Carlsbad, California) ventilator, and (2) 10 patients receiving high or low 
flow oxygen (Optiflow, Fisher&Paykel Healthcare, Auckland, New Zealand) via the 
tracheostomy while undergoing spontaneous breathing trials (SBT) at the time of 
recruitment. As per the data collection processes outlined in the previous study, there were 
four 15 minute time periods for data collection: baseline ventilation (Baseline, no SV); 
silent breathing with SV in the ventilation circuit (PMSV); talking with SV in the ventilation 
circuit (PMSV-T), and return to baseline ventilation (Post-PMSV, no SV) making it a total of 
one hour of continuous measurements. As per study protocol [120] the set PEEP from the 
ventilator was lowered by 5cmH2O for the duration of SV use (time periods SV and SV-T) 
to accommodate for restored physiological PEEP. No changes were made to settings for 
patients on SBT.
4.1.3.2 Data analysis
The EIT data analysis tool 6.1 was used to assess distribution of EELI and TVar in 4 ROIs. 
This tool enabled use of breath-by-breath raw data to calculate the results and 
significance. EITdiagTM was utilised to generate values for VSA and RVD (maximum
regional impedance change set at 40%). A threshold of impedance change >15% per pixel 
was set for both to suppress minor impedance changes caused by noise or cardiac 
oscillations in non-ventilated regions. No Medibus data were available due to the PB840 
ventilator not being able to be connected to EIT equipment, therefore compliance data 
could not be calculated. EITdiagTM produces average values for each time period for the 
user with no access to breath-by-breath raw data, substantially reducing the number of 
data points available for statistical analysis. All of the above mentioned variables were 
analysed firstly as a global measure of the lungs and then separately in 4 ROIs - dorsal, 
ventral, right and left. An example of VSA and RVD across the 4 time-points is given below 
in Figure 4-1.
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Figure 4-1:  Example VSA and RVD as displayed on EITdiagTM
RVD (RVD40 on graph) – regional ventilation delay; VSA (SURF on graph) – ventilated surface area
The   VSA   image   describes   the   size   and   the   location of   ventilated   regions   of   the corresponding 
section. A pixel whose regional impedance change exceeds a certain threshold (>15% in our study) is 
interpreted as ventilated and displayed in white colour. A light grey line is used to illustrate the contour of 
ventilated area surrounding all pixels that have been ventilated at least temporarily in any of the defined 
sections.
RVD image expresses the delay between the global start of inspiration and the point in time, where the 
regional impedance curve reaches a certain impedance change. 
A value greater than 0 is interpreted as a delay of the inspiration (red colour) and a value less than 0 is 
interpreted as early inspiration (blue colour) [125].
STATATM (version 12.0) was used to calculate and present the mean/median values, 
standard error of the mean/interquartile range, and p values for each of the variables for 4 
different time points. An a priori power analysis was conducted for the original study [120]
with breath-by-breath data available in the original EIT data analysis tool. The same 
participant numbers may therefore not be powered for the new EITdiagTM tool making this 
part of the study a feasibility study.
For all data that was not normally distributed at baseline (VSA, RVD), summary statistics 
are reported as median (IQR). Mann Whitney U-test was used for the analysis and 
baseline comparisons between ventilated and non-ventilated patient groups. Shapiro-Wilk 
test was used to test normality with a p<0.05 considered as statistically significant.  Kernel 
density plots are displayed for VSA and RVD to demonstrate the overall shape of the data 
distribution, as well as range, measure of central tendency (mean, median or mode(s)), the 
degree of spread (variance), skew (left or right tailed) and kurtosis (pointedness). P-values 
are included for each curve and indicate the probability that the data distribution is 
normally distributed. Thus a P-value < 0.05 indicates a data distribution that is non-normal. 
4.1.4 Results
Twenty patients with an average age 60 +/- 15 years (50% male) were recruited to the 
study. Ten patients were receiving continuous PSV and the remaining 10 were undergoing 
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SBTs, 9 of whom had required support from the ventilator in the preceding 24 hours (see
Table 4-1).
Table 4-1 – Demographics and ventilation data upon recruitment
Pt 
No
Age
a
Gender
a
Primary 
reason for 
ICU 
admission
vent 
duration 
(# days)
Resp 
support 
mode
a
PEEP
a,b
PS
a,b
Flow
a
FiO2
a
1 63 M Cardiac Sx 19 HFTP - - 40L 40%
2 48 F Cardiac Sx 15 HFTP - - 40L 40%
3 72 F
ENT Sx -> 
Cardiac Sx
5
c
LFTP - - 5L 30%
4 71 M Cardiac Sx 5 HFTP - - 50L 40%
6 77 M Cardiac Sx 9 HFTP - - 50L 40%
7 44 F Cardiac Sx 13 HFTP - - 40L 40%
9 61 M Respiratory 13 HFTP - - 50L 50%
11 70 F Cardiac Sx 13 HFTP - - 40L 40%
14 70 F Respiratory 30 HFTP - - 30L 30%
15 58 M Respiratory 5 HFTP - - 40L 40%
5 29 M Cardiac Sx 15 PSV 5 10 - 40%
8 33 F Cardiac Sx 12 PSV 10 15 - 35%
10 70 M Cardiac Sx 13 PSV 10 13 - 40%
12 43 F Cardiac Sx 6 PSV 7.5 10 - 40%
13 47 F Respiratory 8 PSV 5 15 - 35%
16 62 F Respiratory 9 PSV 8 10 - 40%
17 74 F General Sx 28 PSV 5 10 - 35%
18 78 M Cardiac Sx 10 PSV 5 12 - 40%
19 60 M Thoracic Sx 13 PSV 8 12 - 45%
20 77 M Cardiac Sx 10 PSV 7.5 12 - 40%
a
data from Sutt et al [120]
b
measured in cmH2O
c 
had not needed mechanical ventilation in the preceding 24hrs to being recruited in the study
# - ‘number of…’; ENT – ear-nose and throat; FiO2 – fraction of inspired oxygen; flow – flow of gas; HFTP –
high flow tracheostomy piece; LFTP – low flow tracheostomy piece; PEEP – positive end-expiratory 
pressure; PS – pressure support; PSV – pressure support ventilation; vent duration – ETT+TT period in 
days; Sx – surgery
At baseline the two groups of patients did not statistically differ on any variables (see Table 
4-2 below). Descriptively, however, the ventilated group tended to have values indicative 
of increased lung recruitment across all three variables (TVar, VSA, RVD).  Due to a 
similar trend in EELI between groups across time-points in the original study [120] and 
non-significant differences between the two groups on the global analyses at baseline for 
the new variables, all subsequent data analysis was conducted as single group (n=20).
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Table 4-2 – Global measures of TVar, VSA and RVD (no units)
Ventilated Non-ventilated p-value
TVar at baseline
a
2018.5
1158.2-3160.8
1870.8
1354.2-2552.3
0.36
VSA at baseline
b
432.5
262.0-440.0
356.0
251.0-414.0
0.33
RVD at baseline
b
6.69
5.45-9.29
9.45
7.14-10.50
0.13
a 
analyses performed on dataset with 7981 observations (3995 ventilated, 3986 non-ventilated)
b 
analyses performed on dataset with 20 observations (10 ventilated, 10 non-ventilated)
Mean EELI was observed on average to significantly increase in most lung sections across 
the time periods. The exceptions were a significant drop in EELI in the dorsal lungs during 
the first 15 minutes with SV (PMSV) and a non-significant drop on the left side during the 
same time period (see Table 4-3). EELI increased significantly throughout the next 15 
minutes in both of these areas with patients talking (PMSV-T), with a further significant 
increase in all areas once the SV was removed.
Table 4-3 – EELI and TVar (no units)
Baseline PMSV PMSV-T Post PMSV
EELI
left
mean (SE) 586 (13) 565 (15), 
p=0.28 (#)
766 (14), 
p<0.001
1093 (20), 
p<0.001
right
mean (SE) 585 (15) 702 (20), 
p<0.001
1226 (21), 
p<0.001
1526 (24), 
p<0.001
ventral
mean (SE) 532 (18) 705 (23), 
p<0.001
1054 (23), 
p<0.001
1427(31), 
p<0.001
dorsal
mean (SE) 639 (12) 561 (15), 
p=0.01 (#)
938 (17), 
p<0.001
1192 (12), 
p<0.001
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Baseline PMSV PMSV-T Post PMSV
TVar         global
median
IQR
1947 
(1315, 2799)
1885 
(1237, 2909)
p=0.94
2180 
(1458, 3208)
p<0.001
2217 
(1502, 3184)
p<0.001
left 
median (%)
IQR (%)
39
30-46
36
24-46
p<0.001
38
23-45
p<0.001
38
29-46
p=0.03
right
median (%)
IQR (%)
61
54-70
64
54-76
p<0.001
62
55-77
p<0.001
62
55-71
p=0.02
ventral
median (%)
IQR (%)
42
32-50
39
27-49
p<0.001
41
28-50
p<0.001
42
33-49
p=0.005
dorsal
median (%)
IQR (%)
58
50-68
61
51-72
p<0.001
60
51-72
p<0.001
58
51-67
p=0.002
# denotes a decrease from baseline
A significant increase was detected in Global TVar during the second half of SV use 
(PMSV-T), followed by a further increase once the SV was removed (see Table 4-3). 
Additional observations were that an increase in TVar occurred at the beginning of each 
time period (see Graph 4-1), returning to baseline midway during each time-point. 
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Graph 4-1 – Tvar across time-points
There were no statistically significant changes detected in global or regional VSA (see
Table 4-4). Descriptively, there was an increase in VSA noted with introduction of a SV, 
which continued to increase post SV use.  When looking at ROIs separately an increase in 
VSA was more visible in the right and dorsal sections of the lung. 
Table 4-4 – Distribution of VSA and RVD (no units)
Baseline PMSV PMSV-T Post PMSV
VSA        global
median
IQR
363
257-433
376
275-442
p=0.76
383
288-438
p=0.74
384
277-451
p=0.46
left
median
IQR
180
112-203
173
120-215
p=0.97
178
127-219
p=0.94
188
140-210
p=0.63
right
median
IQR
204
165-226
203
167-227
p=0.99
207
171-225
p=0.98
211
177-229
p=0.52
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Baseline PMSV PMSV-T Post PMSV
ventral
median
IQR
176
109-207
161
108-214
p=0.91
175
118-206
p=0.91
191
125-214
p=0.55
dorsal
median
IQR
203
134-228
216
175-234
p=0.36
209
161-232
p=0.44
221
167-231
p=0.53
RVD          global
median
IQR
8.7
6-9.9
7.4
4.8-12.5
p=0.81
7.7
6-10.3
p=0.80
7.6
4.6-11
p=0.50
left
median
IQR
8
5.4-10.6
6.5
4.2-10.8
p=0.57
7
5.9-9.1
p=0.78
7.8
5.2-10.2
p=0.74
right
median
IQR
8.7
5.8-10.1
8.5
4.1-11.8
p=0.96
8.8
5.5-11.7
p=0.96
7.7
3.9-9.7
p=0.40
ventral
median
IQR
7.1
5.9-12
7.4
5.1-13.1
p=0.83
7.3
5.5-10.3
p=0.57
7.4
4.4-12.7
p=0.63
dorsal
median
IQR
7.8
5-10
7.5
4.5-11.3
p=0.96
7.7
5.6-10.5
p=0.72
6.5
4.4-10.8
p=0.56
The Kernel density plot displays the VSA data across the 4 time-points (see Graph 4-2), 
highlighting the flattening of data clustering around the 230 mark and indicating a general 
shift in the data to the right (towards higher VSA) during and post SV use. With the 
exception of the PMSV-T data, all curves are not normally distributed and generally 
bimodal with peaks around 230 and 400.
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Graph 4-2 - Kernel Density plot for VSA
No significant differences in RVD, either globally or for each ROI were found (see Table 4-
4). Descriptively, global RVD was found to be lower during and post SV use with a general 
pattern of decreased RVD in the left, right and dorsal lung sections. The Kernel density 
plot further describes the RVD data across the 4 time-points and indicates reduced data 
spread and lower RVD values during and post SV use (see Graph 4-3). With the exception 
of the right-skewed Baseline data, all other plots were normally distributed with means 
around 8. Exclusion of outliers above 20 resulted in normally distributed Baseline data.
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Graph 4-3 - Kernel Density plot for RVD
4.1.5 Discussion
Describing research in the area of EIT is a difficult task due to lack of consistent 
terminology and variability in methods used by different authors. Recent publication by the 
TREND group [130] is an excellent attempt to streamline EIT image analysis and 
interpretation. In this current manuscript all efforts were made to ensure clarity of methods 
and consistency with terminology comparable to previously published studies.
This study analysed ventilation distribution in tracheostomised patients weaning from 
mechanical ventilation patients using a number of EIT parameters in order to better 
understand the effect of previously reported increases in EELI attributable to SV use. If the 
increased EELI caused hyperinflation in some areas, this would be associated with 
increased risk of lung disease. However, we have demonstrated on this current small data 
set that the increase in EELI [120] was uniformly distributed throughout the lung, with 
significant increase in all ROIs. Accompanied with improvements in bedside respiratory 
markers, such as significantly decreased RR and reduced EtCO2 from our previous study 
of the same cohort [120], the increased EELI is therefore less likely to indicate over-
distension of the lungs.
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EITdiagTM appears to be a useful clinical tool as it quickly displays trends in ventilation 
distribution and alveolar recruitment between time points. One limitation of the current
technique is that it provides only data averages rather than raw data. Hence it may be less 
effective in determining significance for research purposes, as it results in a restricted raw 
data set per variable. In our study therefore, analyses for VSA and RVD were performed 
on 20 observations per variable, whereas analyses for EELI distribution and TVar there 
were 7981 observations at baseline alone – a 300-fold increase in data points. This made 
reaching statistical significance for VSA and RVD difficult to achieve with current 
participant numbers. Despite their lack of significance statistically, these valuable data 
provide further tools to clarify ventilation distribution with SV use. Despite the VSA and 
RVD data showing non-significant changes between time periods, these values were 
noted to accurately display differences between the ventilated and non-ventilated group of 
patients (see Table 4-2), making the analysis tool more reliable. 
Over-distension of the lung as a consequence of increased EELI would be supported by 
reduced VSA with increased RVD, potentially alongside increased TVar and significantly 
altered EELI distribution (increase in EELI in some areas, and decrease in others). These 
patterns were not consistently detected in our data despite the statistically non-significant 
findings. Conversely, some indicators for potential recruitment were detected such as a 
relatively evenly spread EELI increase, together with a trend towards increased VSA
coinciding with a decrease in RVD, both globally and in separate ROIs. Surprisingly, this 
was the case regardless of the patients’ respiratory requirements.
Upon analysing the 4 time points in more detail, an increase in EELI was noted to be well 
aligned with other variations in right to left sections of the lung (TVar and VSA also 
increased and RVD reduced indicating potential recruitment), but opposite in dorsal to 
ventral direction (an initial decrease in EELI coincided with an increase in TVar and VSA
and a decrease in RVD, all suggesting potential recruitment despite reduced EELI). It has 
to be noted that these are trends only, and due to no significant correlations, it is not 
possible to make further assumptions of these data relating to anything clinically 
significant. Larger studies are needed to look at the potential effect of SVs on ventilation 
distribution, and its potential for lung recruitment. 
In addition to heterogeneous breathing patterns observed in spontaneously breathing 
patients, it is likely that ventilation changes are impacted upon by the patients’ ability to 
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close their glottis against high pressures (generating variable upper airway resistance for 
closure during inspiration from the ventilator) and the ventilator’s ability to trigger PEEP 
and compensate for the leak with a one-way valve in-situ. Patient and ventilator synchrony 
(in other words respiration-phonation coordination during SV use) is something that 
speech pathologists can work on with spontaneously breathing patients using a SV. The 
PB840 ventilator used in this study performs well with most patients when the SV is used 
in NIV mode. This is not the case with many other ventilators that do not cope with such a 
leak in the ventilatory circuit [131-133]. The specific make of ventilator could therefore 
have a significant effect on being able to successfully use a SV in-line with mechanical 
ventilation circuit.
Another important variable is the space between the deflated cuff and patient’s trachea 
causing resistance to exhalation when SV is used. Sufficient space is needed around the 
deflated cuff to avoid air trapping and potential hyperinflation of the lungs. In the ventilated 
population, we look for a significant drop in expired TVs (usually 40-60%) once the cuff 
has been deflated to determine the patient’s suitability for SV use. In spontaneously 
breathing patients this is less precise with a reliance on patient comfort and respiratory 
parameters during digital occlusion of the TT for expiration during cuff deflation.
Patients have identified communication difficulties as one of the main sources of frustration 
for them whilst ventilated in ICU. This has reportedly led to social withdrawal, reduced 
motivation to participate in care, depression, poor sleep with increased anxiety and stress 
levels [7-11]. The results of the current study have led to wide use of SVs in the ICU where 
the study took place. Using SVs is now routine practice [108] and has become increasingly 
common with very sick tracheostomised patients [134]. Patients have reported feeling their 
autonomy returning when able to speak again, and feeling as part of the human race 
again. Having these patients talking makes it easier to look after them for the whole ICU 
team.  Although these data may not be able to be extrapolated to other clinical 
populations, these should be encouraging towards wider use of SVs with the cardio-
thoracic cohort.
4.1.5.1 Limitations of the study
The biggest limitation in such detailed analysis of ventilation distribution was low patient 
numbers and the inability to access raw data with the new data analysis tool. In such an 
inhomogeneous group of spontaneously breathing patients, several outliers added to the 
difficulty of seeing any significant changes.
64
EITdiagTM adds valuable options to further analyse ventilation distribution, however the 
current set-up of the tool makes analysing data from spontaneously breathing patients 
rather difficult, with suitability for use in research being questionable. The tool averages 
data for the user, therefore limiting the amount of data available for analysis, thereby 
making it less meaningful. To achieve significance in findings, one would need to 
investigate a lot more patients, or have access to all of the raw data.
RVD has been shown to give accurate data during 12-mL/kg slow insufflation manoeuver 
by Wrigge [123], later confirmed by Muders [125]. In our case, the data were from 
spontaneously breathing patients, therefore we cannot know with certainty that the RVD 
index relates to cyclic opening and closing of the alveoli. However, the algorithm, which is 
used in the EITdiagTM software does not consider that a slow inflation manoeuver is 
required for calculating the RVD and regardless calculates RVD for each section. Hence 
the algorithm is not exactly correlated to protocol by Wrigge [123], as stated in the 
EITdiagTM user manual . 
Additional and more precise data may be gained in future studies by obtaining 
simultaneous airway pressure data directly alongside with EIT data collection. Due to the 
use of ventilators other than Dräger in the ICU where the study took place, it was not 
possible to obtain such data alongside our EIT data. Due to the same reason, Medibus 
data for additional EIT data analyses (such as compliance data) could not be captured.
EIT data is highly dependent on the belt position, and only captures data from the segment 
of lung where the EIT belt is situated [51, 52]. Therefore these images do not necessarily 
detect ventilation changes in the whole lung.
Clinically, similar patients are using SVs for much longer duration at a time. Due to 
difficulties of maintaining patient position and keeping the EIT belt in-situ for more than one 
hour, it is unclear whether similar patterns of ventilation distribution occur with longer 
duration of SV use.
4.1.6 Conclusions 
Analysing lung recruitment using EIT is still novel, and is certainly more difficult in 
spontaneously breathing patients with limited options for airway pressure measurements 
alongside EIT. Given the previously published data on increased EELI it was necessary to 
clarify regionality of ventilation distribution in these patients. This change in EELI caused 
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non-significant changes in EIT parameters used to detect recruitment or over-distension 
with the data trend favoring recruitment. Therefore the concern that cuff deflation together 
with SV use in patients undergoing weaning from mechanical ventilation may cause lung 
derecruitment seems unfounded. This, along with obvious psychological benefits to 
patients and previously published gas exchange data [120], serve to support the wide use 
of SVs in cardio-thoracic patients weaning from mechanical ventilation. 
For similar in-depth analysis of ventilation distribution in the future a bigger sample size is 
needed. The manufacturers should allow analysis of raw data as well as the averaged 
data, as this too will allow a more definite answer to similar questions that clinicians may 
have in the future.
4.2 Diaphragm activity
The importance of respiratory muscles, including the diaphragm, in respiration has been
discussed previously in Chapter 2. The preceding manuscript (4.1) gave an overview of 
ventilation distribution with SV use. Another aspect of respiration that is interlinked with 
changes in EELI and its distribution is respiratory muscle activity.
4.2.1 Background
It is known that ventilator-induced diaphragm weakness develops rapidly, with signs of 
deterioration demonstrable within 18 hours of mechanical ventilation initiation [59].  
Generally, days or weeks of mechanical ventilation via an ETT precede a tracheostomy. 
Therefore tracheostomised mechanically ventilated patients are likely to have developed 
diaphragmatic weakness. The partial restoration of negative pressure ventilation with SV 
use, and patients taking larger breaths during talking, may lead to changes in patients’ 
intra-thoracic and abdominal pressures.  Hence, SV use may result in different levels of 
diaphragmatic involvement in breathing, with diaphragm involvement likely to be highly 
dependent on the level of pre-existing diaphragm weakness. RIP belts can measure 
abdominal and chest volume changes during breathing. Increased abdominal volume 
change compared to chest volume may predict increased diaphragmatic involvement. 
There has been limited research on A:C ratio when breathing at rest and comparing this to 
period of verbal communication [60]. There have also been differences reported due to 
age [135] and disease process [136]. This study’s primary hypothesis was that there would 
be a shift towards increased abdominal activity when SVs were used compared to closed 
circuit ventilation with an inflated cuff. RIP was chosen as the most pragmatic tool to 
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measure A:C ratio and predict diaphragm activity in a cardio-thoracic ICU population 
weaning from ventilation whilst using a SV.
4.2.2 Methods
The same 20 participants described in chapter 3 and section 4.1 of this chapter were 
included in the study. A respiratory inductance plethysmograph system with self-calibration 
functionality, ‘Respitrace QDC’ (CareFusion Corporation, San Diego, USA), was used to 
measure abdominal and chest mobility (volume change) simultaneously with EIT 
measurements reported in Chapters 3 and 4. Two RIP belts were used; one around the 
patient’s chest at the level of C5-6 directly over the EIT belt, and the second RIP belt 
around the patient’s abdomen at the umbilical level (as shown on Figure 2-5 in Chapter 2). 
Data recording was continuous over 60 minutes, with periods of interest including Baseline
(first 15 minutes + last 15 minutes), PMSV with SV in-situ, quiet breathing and no talking 
(second 15 minutes), and PMSV-T, SV in-situ with active talking (third 15 minutes). 
4.2.2.1 Data analysis
The continuous RIP data was recorded at 1kHz (PowerLab 8/30, ADInstruments and 
LabChart 7.0, ADInstruments) from the chest and abdominal belts separately. Data were 
analysed (LabCHart 7.0, ADInstruments) to calculate A:C ratio for each of the three time-
periods (baseline, PMSV, PMSV-T). The program combined the first and the last 15 
minutes of observations together automatically, generating data for baseline period. A:C 
ratio data were normally distributed. Paired t-tests were used to compare A:C ratio for 
combined baseline and SV periods, after first determining there was no significant 
difference (p=0.21) in A:C ratio between the PMSV and PMSV-T periods (GraphPad 6 and 
SPSS). Comparison of A:C ratio in both conditions (baseline and SV) was also completed 
for the two patient groups (PSV vs HFTP).
4.2.3 Results
Twenty patients with an average age 60 +/- 15 years participated in the study. Ten 
patients were receiving PSV and 10 were on HFTP during recruitment into the study. 
Measurements were unable to be analysed for one patient out of 20 due to equipment 
failure during data collection. 
Initial group comparison (n=19) revealed a significant increase in A:C ratio from 1.3 to 1.5 
(p=0.047), indicating increased abdominal mobility suggestive of increased diaphragm 
activity when the SV was put in-line (Baseline compared PMSV). While no significant 
difference was found between PMSV and PMSV-T periods, it was noted descriptively the 
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A:C ratio was smaller for 12 of the participant once they started talking (p=0.98). 
Descriptively 80% of ventilated patients showed an increase in A:C ratio (p=0.039) during
the PMSV period as opposed to 67% of patients that were receiving high flow oxygen 
(p=0.552) through their TT during recruitment to the study (see Table 4-5 below). For six 
patients, the A:C ratio dropped below baseline once the patients started talking. These 
data indicate that for these patients there was more movement of the chest once they 
started talking. One patient showed an opposite response – increased abdominal mobility 
once they started talking. No gender differences in the results could be identified. All 
patients that had been mechanically ventilated for <9 days showed increased A:C ratio 
with SV use (n=5). At the same time, one patient that had been ventilated for 28 days also 
showed increased A:C ratio with SV use. Individual A:C ratios across the three time-
periods are presented in Table 4-5 below. 
Table 4-5 – Gender, ventilation status, ventilation duration and A:C ratio
Participant 
number
Gender Vent 
status
Vent 
duration 
(# of days)
A:C ratio 
Baseline
a
A:C ratio 
PMSV
a
A:C ratio 
PMSV-T
a
1 M HF 19 2.07 2.84 1.24
2 F HF 15 1.82 1.46 1.63
3 F HF 5 0.57 0.84 0.36
4 M HF 5 1.04 1.07 1.59
6 M HF 13 N/A N/A N/A
7 F HF 13 3.12 3.24 1.36
9 M HF 30 1.18 1.24 1.77
11 F HF 15 1.28 1.70 0.70
14 F HF 6 0.76 0.93 0.87
15 M HF 8 1.96 1.27 2.14
5 M PSV 9 1.02 1.01 0.99
8 F PSV 13 3.76 4.99 4.46
10 M PSV 5 0.64 1.24 1.37
12 F PSV 12 0.59 0.39 0.44
13 F PSV 13 0.54 0.92 1.12
16 F PSV 9 1.64 1.84 1.92
17 F PSV 28 0.92 1.44 1.08
18 M PSV 10 0.65 0.93 0.89
19 M PSV 13 0.98 1.09 0.57
20 M PSV 10 0.39 0.40 0.38
a
higher value in A:C ratio means more abdominal activity relative to chest
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4.2.4 Discussion and conclusions
Upon the initial introduction of the SV, an increase in A:C ratio was observed across the 
cohort. However, the tendency for the A:C ratio to be smaller once the patients started 
talking, was surprising. As preparation for an utterance usually includes taking a larger 
breathe, it was hypothesised that the patients would use their diaphragm more during the 
talking phase, and therefore show increased abdominal mobility during SV use. This 
increase was not observed, which may be attributable to the variable degree of 
diaphragmatic atrophy between patients. It may also indicate that patients were trying to 
compensate for lack of diaphragm involvement by utilising the muscles around their 
thoracic cage when needing to take a larger breath.
It was hypothesised that duration of mechanical ventilation prior to recruitment to the study 
may impact the probability of increased A:C ratio with SV use. This relationship was not 
observed in this the small cohort of patients. 
The inconsistent data from this study highlight the known limitations when choosing a 
measurement device for such detailed analysis of A:C ratio on a small critically ill patient 
cohort with variable durations of mechanical ventilation prior to the study. These patients 
were likely to have variable levels of diaphragmatic dysfunction prior to being enrolled in 
the study, relating to a range of potential variables that include pre-existing pathologies, 
cause for mechanical ventilation, levels of participation in physiotherapy, nutritional status 
etc. Data on diaphragmatic recovery has not been adequately described in literature to 
determine whether a short intervention, such as 30 minutes of SV use, could impact 
diaphragm mobility or recovery. This could also depend on the fibre types and the level of 
remaining muscle thickness of the diaphragm.
The increased abdominal mobility observed in this study is suggestive of increased 
diaphragm activity. To confirm this, further data are required using additional techniques 
more suited to direct diaphragmatic measurements, such as using NAVA probes [63-65], 
diaphragm ultrasound [68-70] or transdiaphragmatic pressure [67] as described in Chapter 
2. Lack of data into such an important muscle of respiration necessitates further research 
into the impact of mechanical ventilation on the diaphragm, and the most efficient ways to 
rehabilitate it. 
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Chapter 5 Tracheostomised patients with obstructive airways disease – can 
speaking valves be used?
5.0 Rationale and significance
Chapters 3 and 4 gave an overview of EELI and ventilation distribution of tracheostomised 
ICU patients using a SV whilst undergoing weaning from mechanical ventilation. All of 
these patients presented with acute lung injury (without chronic respiratory condition), 
which was improving at the point of inclusion into this study. There was substantial 
uniformity in the response of all patients’ respiratory systems to SV use – showing 
significantly increased EELI and signs of recruitment in several ROIs in the lung. However, 
not all patients and all diseases are equal. Patients with obstructive lung disease could 
potentially have a significantly different respiratory response to SV use since their EELVs 
are already high at baseline. This chapter presents a case report describing the effects of 
SV use in an undiagnosed COPD patient. The specific SV used in this study is a Passy 
Muir SV (PMV007, Passy Muir Inc., California, USA).
This study contributes to the main aim of the thesis. It was designed to monitor the 
patient’s lung mechanics before, during and after SV use and analyse the following key 
variables: (1) SpO2; (2) EELI and its distribution; (3) TVar and its distribution; (4) VSA; (5)
RVD; (6) centre of ventilation (CoV), and (7) region of no ventilation (rNoVent).
This is the first attempt to describe lung mechanics of a patient with chronic obstructive 
lung disease when using a SV. Whilst a single case report, it highlights the importance of 
understanding the patients’ pre-existing lung condition and the physiology that determine 
this.  The pathophysiological pulmonary process may be exacerbated by the physiological 
effects of SV, and the two combined may lead to harm.
The results of this study were presented in abbreviated form as a poster presentation at 
ANZICS conference, and have been published in an abstract format as listed in Published 
abstracts on page vi. Formatting of the manuscript is according to the style of Journal of 
Critical Care. Sections, tables and figures have been numbered to align with the rest of the    
thesis document.
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Tracheostomised patients with obstructive airways disease – can speaking valves 
be used?
Sutt A-L, Caruana L, Cornwell P, Fraser JF
Submitted to Critical Care and Resuscitation in April 2017
5.1 Introduction
The use of SVs in tracheostomised ventilated patients is increasing substantially due to 
recent positive data regarding their efficacy and safety [90, 107, 108]. However, research 
data to guide optimal patient selection for SV use is lacking. One of the key mechanisms 
by which a SV appears to improve respiratory function is through its action as a “PEEP 
valve”. This action results in an increase in EELVs that continues post SV removal [120]. 
Extra PEEP, however, could adversely affect patients with COPD – a hallmark of which is 
persistent hyperinflation of lungs at baseline. 
5.2 Rationale 
Whilst recruiting patients to a previously reported study by our group [120, 137], one 
patient in whom no past medical history of respiratory disease had been reported suffered 
a significant drop in oxygenation when a SV was attached to his TT in-line with high-flow 
oxygen therapy. This could not be rectified even when correcting the airflow (L/min) and 
FiO2. This occurred in the context of no obvious change in comfort or WOB for the patient. 
The aim of this case report is to explore the cause for this desaturation and thereby inform 
best clinical practice for SV use in patients with obstructive lung disease.
5.3 Case report
5.3.1 Patient background
A 51 year-old gentleman was admitted to ICU following a 16-minute downtime till return of 
spontaneous circulation following an out of hospital cardiac arrest. The medical history 
available on admission included paranoid schizophrenia and substance abuse. Bystander 
cardiopulmonary resuscitation (CPR) resulted in left-sided anterolateral fractures of the 
2nd, 3rd and 4th rib, as reported by a radiologist based on a series of chest X-rays. No 
obvious signs of hypoxic brain injury were reported. The patient required stenting of his 
right coronary artery.
Nothing in the medical history and blood gas analysis excluded the patient from 
assessment and use of SV. SP had been unsuccessfully trialing a SV for short periods 
with the patient for several days, initially in-line with mechanical ventilation. The patient 
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was desaturating with SV in-situ, despite showing no change in his WOB. CO2 retention
was not observed during weaning from mechanical ventilation. Admission and first 24-hour 
blood gases can be seen in Table 5-1.
Table 5-1 - Blood gases on admission
Day 0
11am
Day 0
2pm
Day 0
8pm
Day 1
3am
PaCO2 (mmHg) 52 38 34 36
PaO2 (mmHg) 149 81 84 62
Bicarbonate 
(mmol/L)
26 26 24 27
Base excess 
(mmol/L)
-0.4 2.0 1.0 3.6
pH (mol/L) 7.32 7.44 7.47 7.48
At time of determining the patient's suitability for recruitment to the study (day 16 in ICU, 
day 11 with tracheostomy) the patient was being liberated from mechanical ventilation, 
spending most awake hours on HFTP. 
5.4 Methods
Due to the limited bedside data available to detect the cause for desaturation during SV 
use, EIT was used to assess regional ventilation and indicate potential aetiologies for the 
abnormal gas transfer issues.  EIT has been used in numerous studies to investigate the 
volume and distribution of gas in the lungs, including in the COPD population [138, 139]. It 
is a non-invasive, radiation free bedside imaging tool that allows for monitoring of patients’ 
breathing in real time by using an electrode belt around their chest [130]. Previously EELI 
and EELI distribution were the primary measures used with EIT. EELI has been shown to 
be highly correlated with EELVs [48, 50]. In recent times, a broader range of data has
been able to be extracted and analysed using EIT. Variables such as RVD, VSA, CoV, and 
rNoVent are enabling an improved understanding of lung recruitment [56, 122, 125]. Ethics 
approval (HREC/13/QPCH/95) from local ethics committee was gained, an altered 
methodology similar to the research protocol described in Chapters 3 and 4 was utilised.
Following patient consent, the patient’s breathing was monitored with EIT before, during 
and after short term SV use, to clarify regional ventilation and investigate potential 
aetiologies that could explain the desaturation.
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EIT (Drager, Lubeck, Germany) was used for continuous measurements over 33 minutes. 
Data were captured at 20Hz with the patient sitting up in a regency chair. EIT data were 
captured for 5 minutes at baseline with the patient receiving 40L/min of 40% oxygen 
through his tracheostomy. The tracheostomy cuff was then deflated and a SV (PMV007, 
Passy-Muir, Irvine, California, United States) was inserted in-line with the HFTP tubing. 
The SV was removed and cuff re-inflated 21 minutes later. EIT measurements continued 
for another 7 minutes. A total of 33 minutes continuous measurements were taken. SpO2
was monitored throughout data collection. EIT data analysis 6.1 (Drager, Lubeck, 
Germany) was used to calculate EELI and TVar, both global and regional across all 3 
time-periods. EITdiagTM (Drager, Lubeck, Germany) was used to calculate RVD, VSA, 
CoV and rNoVent across the same time-periods. 
5.5 Results
A significant increase in global EELI (by 33%, p<0.001) was observed during SV use, 
coinciding with a significant drop in SpO2 (96% -> 86%) over 21 minutes. The increase in 
EELI was evenly distributed (see Figures 5-1a and 5-1b) with a significant increase in all 
lung sections during SV use. A drop to below baseline (globally by 40.7%, p<0.001) was 
observed in all sections after the SV was removed. SpO2 rapidly increased back to 
baseline post removal of the SV.
Figure 5-1a: EELI distribution in right-left direction across time-periods
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Figure 5-1b: EELI distribution in anterior-posterior direction across time-periods
Global TVar increased by 23% during SV use (p<0.001), dropping back to below baseline 
once the SV was removed (globally by 20.1%, p<0.001). There were no significant 
changes in TVar between different lung sections (see Figures 5-2a and 5-2b).
Figure 5-2a: Distribution of TVar in right-left direction across time-periods
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Figure 5-2b: Distribution of TVar in anterior-posterior direction across time-periods
An increase in RVD was noted during SV use (3.65->12.48, no units), which dropped once 
the SV was removed (11.29). VSA showed a decrease (508->451->489, no units) during 
SV use, and remained below baseline once the SV was removed, see Figure 5-3. rNoVent 
increased from 0.37 at baseline to 12.55 during the SV period and dropping to 2.06 post 
SV use. This correlates with RVD and VSA, indicating a bigger area that was not 
ventilated during SV use, despite the increase in EELI. CoV shifted during SV use as can 
be seen in Figure 5-3. During SV placement the CoV reduced to 50 on the right and 49 on 
the left compared to baseline of 54 and 50 equivalently. This indicates a shift in ventilation 
towards the dorsal aspects of the lungs on the right side during SV use.
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Figure 5-3: RVD (RVD40 on graph), VSA (SURF on graph) and CoV (CG on graph) across 
time-periods. Screenshot from EITdiagTM
RVD40 – indicates a delay in opening of alveoli in certain lung regions. The bigger the 
number, the greater the delay; VSA – indicates ventilated surface area on the lung. The 
bigger the number the greater the ventilated surface area; CoV –indicates the centre of 
ventilation taking into account right-left and anterior-posterior shifts in ventilation.
Further examination of the patient’s chest x-rays revealed substantial hyperinflation, which 
was considered to be consistent with probable COPD (see Figure 5-4 below). Patient 
questioning (only able to be done with SV in-situ) regarding his exercise tolerance and 
chronic cough confirmed that this had gone undiagnosed prior to this admission.
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Figure 5-4: Chest XR on the day of recruitment to the study
Chest XR consistent with bilateral hyperinflated lung fields and flattened diaphragms  
5.6 Discussion
Previously published data [137] on ventilation distribution during and post SV use revealed 
increased EELI and TVar similar to this case study, further confirming the effect of SVs on 
respiratory mechanics. However, these findings so far have all been observed on patients 
recovering from acute lung injury and represent a combination of decreased RVD and 
increased VSA with stable or improved oxygenation. In contrast, this case study revealed 
signs of hyperinflation in the lungs during SV use with some recovery observed post SV 
removal. Increased RVD and rNoVent, together with decreased VSA in the setting of 
significantly increased EELI, all indicate potential hyperinflation of the lung. Regional 
analysis indicates potential hyperinflation more in the anterior aspects of the lungs. In a 
previous study [120] on a non-COPD cohort EELI had increased and remained 
significantly above baseline even once the SV was removed. In this case study, however,
EELI dropped to below baseline as soon as the SV was removed. This may also indicate 
stretching of lung tissue, suggesting hyperinflation during SV.
Combining EIT data and the patient’s chest x-ray, it is possible that the patient developed 
ventilation-perfusion inequality [33] during SV use. High ventilation / increased gas flow, as 
indicated by significantly increased EELI and other EIT parameters suggesting 
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hyperinflation of the lungs during SV use, may have caused excess pressure on the alveoli 
resulting in reduced blood flow in the surrounding pulmonary arterioles. In these areas, 
airway pressure may have exceeded arterial pressure, resulting in a shunt which may 
have manifested in a drop in arterial oxygen saturation. 
It is highly likely that SV use resulted in increased PEEP for this patient. High flow oxygen 
therapy via a TT provides very little PEEP, if any [140]. SV use restores physiological 
PEEP, with expiration happening via the upper airway. Since the patient has to breathe 
around a deflated cuff and a TT, expiratory resistance is increased with SV use. Previous 
attempts to measure physiological PEEP with SV in tracheostomised patients have had 
little success [120]. Reports of more invasive methods [42] could help target the ‘sweet 
spot’ just below the vocal folds. The trachea to TT size ratio plays a significant role in 
amount of resistance experienced. The size of the TT may be one of the easiest and only 
variables to modify when determining the suitability for SV use in tracheostomised patients 
with obstructive lung disease. 
COPD patients have dynamic airways compression and flow limitation. As a consequence, 
dynamic hyperinflation and intrinsic positive end-expiratory pressure (iPEEP) occur [141, 
142], creating ventilation-perfusion mismatch [143], affecting WOB and gas exchange. In 
mechanically ventilated patients, the ventilator is set to deliver minimal PEEP and allow for 
prolonged expiration time to overcome these consequences. Spontaneously breathing 
COPD patients often use pursed lips breathing in order to achieve the same effect. Pursed 
lip breathing has shown to decrease airway compression [144, 145], and lead to 
decreased RR and increased tidal volumes [145-147]. There have been studies showing 
that applying external resistance to mechanically ventilated COPD patients reduces iPEEP 
and compression of the airways [141, 148]. Other studies with mechanically ventilated 
patients found these PEEP effects damaging [149, 150]. SVs could theoretically have the 
same effect: the added resistance in the upper part of the trachea should act similarly to 
pursed lip breathing. The only exception is the lack of variability during SV use that the
patient could exercise with pursed lip breathing. The resistance to breathing around the 
deflated cuff is constant when a SV is used. The added extrinsic PEEP could be too high 
for some patients using a SV, and thus exceed the critical level of external PEEP as 
described by Tobin [151]. The above mentioned TT to tracheal size ratio could be 
essential in determining the success of SV use in having similar effects to pursed lip 
breathing.
79
SVs have been used as part of routine clinical practice for the past 5 years in the 
cardiorespiratory ICU at TPCH. During this time only a small number of patients have been 
noted to de-saturate significantly with a SV in-situ. While the features of the current case 
are thought to relate to his COPD diagnosis, it should be noted that the ICU frequently 
manages patients with poorly defined obstructive lung disease yet only a few have 
displayed similar features.
5.6.1 Limitations of the study
Whilst merely a single case, the study highlights the fact that SVs may have risks as well 
as benefits. Their use should be considered on a case-by-case basis. One particular 
population where caution may need to be exercised is in patients with severe or covert
COPD. 
The study was unable to capture carbon dioxide measurements or measure pulmonary 
shunt during the investigation, which would have provided further evidence of potentially 
inadequate gas transfer related to SV use in this patient with parenchymal disease.
5.7 Conclusion
This is the first report describing the physiology, and more specifically the lung mechanics, 
of a tracheostomised ventilated COPD patient when using a SV. Confirmation of potential 
lung hyperinflation should help clinicians seek solutions (such as downsizing a TT) to help 
safely facilitate verbal communication with the use of SV in this population. 
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Chapter 6 Impact of speaking valve use on patient outcomes in ICU
6.0 Rationale and significance
Making any changes to the weaning regime (such as using SVs) for patients still needing 
support from the ventilator may result in changes to ICU outcomes, such as time spent on 
the ventilator, number of days from TT insertion to decannulation etc. As the results of the 
studies in Chapters 3, 4 and 5 show, SV use causes an increase in EELI and alters 
bedside respiratory markers, therefore potentially also affecting tracheostomy specific
outcomes. 
Restored upper airway function provides the opportunity for patients to commence
activities such as talking, eating and drinking; all roles of the upper airway. There are no 
published data on the impact of SV use on such outcomes. To address the second aim of 
this thesis, this chapter presents two published manuscripts on tracheostomy and SP 
specific outcomes pre and post the implementation of SV use into ICU. The chapter is 
divided into two parts. The study presented in the first part aims to compare if and how the 
introduction of an in-line SV into ICU impacted the tracheostomy and SP specific 
outcomes for patients.  All tracheostomised patients in the ICU the year before the 
introduction of the in-line SV (2011) are compared to all of the patients with a TT during 
the first year that the in-line SV was introduced into the ICU (2012). Although swallowing 
and dysphagia are not a focus area of this PhD, the outcomes for patients commencing 
oral feeding were included as part of this study to inform future research in the area.
The second part of this chapter contains a study analysing similar outcomes for all 
tracheostomised patients from the following two years (2013-2014), when use of the SV
had become routine clinical practice. It was hypothesised that an in-line SV would improve 
communication and swallowing specific outcomes with no increase in average time to 
decannulation or the number of adverse events.
The findings of the first study were first presented at the International Tracheostomy 
Symposium in Melbourne, October 2014. Since then results from both studies have been 
presented in numerous invited international, national and local lectures as listed in 
Presentations during candidature on page vii. This chapter includes 2 manuscripts, both 
published in Journal of Critical Care in 2015. All sections and tables have been 
renumbered, and abbreviations continued to align with the rest of the thesis document. 
Table 6-2 has an added column with p values.
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Note:
Although the studies in Chapters 3, 4 and 6 occurred at the same time, the timing of the 
publication of these manuscripts in peer reviewed journals means that the conclusions and 
references to gaps in literature in the manuscripts included in the present chapter are not 
inclusive of information in Chapters 3 and 4. 
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6.1 The use of tracheostomy speaking valves in mechanically ventilated patients 
results in improved communication and does not prolong ventilation time in 
cardio-thoracic ICU patients.
Sutt A-L, Cornwell P, Mullany D, Kinneally T, Fraser J
Journal of Critical Care 30(3); Jan 2015
Accepted for publication 28th of December 2014
6.1.1 Abstract
Purpose
The aim of this study was to assess the effect of the introduction of an in-line 
tracheostomy SV on duration of mechanical ventilation and time to verbal communication 
in patients requiring tracheostomy for prolonged mechanical ventilation in a predominantly 
cardiothoracic ICU. 
Materials and Methods
We performed a retrospective pre-post observational study using data from the ICU 
clinical information system and medical record. Extracted data included demographics, 
diagnoses and disease severity, mechanical ventilation requirements, and details on 
verbal communication and oral intake. 
Results
Data were collected on 129 patients. Mean age was 59+/-16 years, with 75% male. 
Demographics, casemix and median time from intubation to tracheotomy (6 days pre-post) 
were unchanged between timepoints. A significant decrease in time from tracheotomy to
establishing verbal communication was observed (18 days pre and 9 days post, p<0.05). 
There was no difference in length of mechanical ventilation (20 days pre-post) or time to 
decannulation (14 days pre-post). No adverse events were documented in relation to the 
introduction of an in-line SV.
Conclusions
In-line SV was successfully implemented in mechanically ventilated tracheostomised 
patient population. This resulted in earlier verbal communication, no detrimental effect on 
ventilator weaning times, and no change in decannulation times.  
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6.1.2 Introduction
An in-line SV is a one-way valve that blocks airflow from returning to the ventilatory circuit, 
and redirects it through to the upper airway enabling functional use of the glottis [152] in a 
tracheostomised patient. The valve is designed to be inserted in-line with the ventilator 
tubing and requires the tracheostomy cuff to be deflated allowing air to bypass the 
tracheostomy cannula and be exhaled through the larynx. In-line SVs have the potential to 
improve the quality of life of tracheostomised mechanically ventilated patients by enabling 
verbal communication and improved swallowing. However, the impact of the valve on 
respiratory mechanics remains unclear. Cuff deflation alongside placement of the SV in-
line creates a leak in the ventilatory system. This has led to concerns that lung 
derecruitment could occur reducing EELV, leading to alveolar collapse and atelectasis. 
This may be deleterious to liberating patients from the ventilator and prolong their length 
of stay in ICU.  There is currently no published research documenting the effect of talking 
with a deflated cuff (leak speech) or SV on EELV, and limited research documenting the 
effect of leak speech or SVs on weaning from mechanical ventilation. 
6.1.2.1 Communication
Communication in mechanically ventilated patients is extremely restricted and in many 
cases is reliant on non-verbal modes (e.g. mouthing, gesture and communication boards). 
The inability to use verbal communication results in decreased exchange of diagnostic 
information between staff and patient, leading to decreased adherence to 
recommendations, therefore poor patient satisfaction with the healthcare service [12]. 
Patients report a preference for verbal communication [6] and have associated the inability 
to verbally communicate with depression, social withdrawal, and reduced motivation to 
participate in care [7-10]. In addition poor sleep, and increased anxiety and stress levels 
have been associated with the mechanically ventilated patients’ inability to effectively 
communicate [11].
6.1.2.2 Swallowing
There are inconsistencies reported as to the effect a TT has on swallowing physiology
[153-163]. By restoring the airflow through the upper airway, return of subglottic pressure 
during swallowing is facilitated [164]. Improved taste and smell have also been reported 
[152, 165]. However, it is unclear if this is necessary for a successful swallow. Practice in 
some ICUs is for tracheostomised patients to be nil-by-mouth until they are able to tolerate 
cuff deflation with or without a SV. This might unnecessarily delay return to activities of 
daily living, and could also lead to increased costs with enteral feeds. Also, 
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tracheostomised patients often report extreme dryness of mouth, thirst and discomfort 
when left nil by mouth [166-168].
In-line SVs have the potential to improve the quality of life of tracheostomised 
mechanically ventilated patients through restoration of communication and eating / 
drinking capacity. However it is important to ensure this benefit is not lost through 
worsening of respiratory function.  A team decision was made to trial implementation of an 
in-line SV for one year with a view to assess patient outcomes with tracheostomies and 
adverse events with the introduction of the in-line SV. The aim of this study was to 
compare tracheostomy outcomes pre and post implementation of the in-line SV over two 
consecutive 1-year periods. 
6.1.3 Materials and Methods
6.1.3.1 Sample
Tracheostomised patients in a cardio-thoracic ICU.
6.1.3.2 Setting
The study was conducted in a university affiliated teaching hospital with 630 acute care 
beds. The ICU is a 27 bed mixed medical surgical adult ICU with a predominantly 
cardiothoracic case-mix, including thoracic organ transplantation and extracorporeal life 
support. Neurosurgical and trauma patients are not managed at the facility. The ICU is 
staffed by a multidisciplinary team (medical, nursing, and allied health) with SP services 
provided as a part-time week day service with an open referral system for 
tracheostomised patients. SP services for tracheostomised patients prior to January 2012 
did not include the provision of the in-line SV. The SVs available in the ICU (Portex 
Orator) were not designed to be used in-line with mechanical ventilation circuits and 
therefore could only be introduced with spontaneously breathing patients that did not need 
more than a couple of litres of oxygen via their TT for respiratory support. This was able to 
be administered via the side port of the SV. In January 2012, in-line SVs (PMV007) were 
introduced to the ICU. These were seen as an option for enabling earlier verbal 
communication due to their design allowing these SVs to be used in the ventilator circuit. 
6.1.3.3 Data collection
Following human research and ethics committee approval (number HREC/13/QPCH/95) a 
retrospective audit was conducted of all tracheostomised mechanically ventilated patients 
managed within the ICU from January 2011 to December 2012. During the period January 
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to December 2011 the ICU used a SV (Portex Orator) that was not designed to be used 
in-line with mechanical ventilation. Patients managed in the ICU between January to 
December 2011 formed Group 1 in the study. January 2012 saw the introduction of an in-
line SV, designed to allow for use in-line with mechanical ventilation tubing to the ICU. 
Patients in the ICU between January 2012 to December 2012 formed Group 2. Data were
obtained from the SP tracheostomy and ICU clinical information system and databases 
and supplemented by data from the medical record. Patients transferred from other ICU’s 
with a tracheotomy in situ were excluded.  One outlier with complications of severe 
pancreatitis leading to tracheostomy duration in excess of 217 days who was nil by mouth 
due to surgical reasons was excluded. In patients where the tracheostomy was reinserted, 
total duration of time was recorded.
6.1.3.4 Outcomes
Data collected on all patients included demographics, tracheostomy / ventilation, 
communication, and swallowing information. Demographic information included age, 
gender, admission diagnoses, surgical interventions, APACHE III and SOFA scores, and 
survival rates in ICU. Tracheostomy and ventilation information included length of 
endotracheal intubation, time to decannulation, and respiratory status/ventilation 
requirements at time of return to verbal communication. Communication and swallowing 
data collected included time to first verbal communication, time to return to oral intake, 
type of initial oral intake (i.e. fluid and / or food consistencies), cuff status at 
commencement of oral intake. All outcome measures that are documented as ‘time to…’ 
or ‘length of…’ were recorded in days.
6.1.3.5 Statistical analysis
Data were collated with subsequent data cleaning undertaken to check for data entry 
errors, with correction of any such errors identified before data analysis. Data were 
checked for skewedness. Descriptive analysis of the data collected for each year was 
undertaken to inspect for and report trends using cross-tabs in SPSS. Comparison of key 
outcomes such as ETT duration, TT duration, days from ETT to TT, days from TT to SV, 
days from SV to decannulation, days from TT to first oral intake, APACHE III and SOFA 
scores were completed using independent t-tests for the Groups 1 and 2 using SPSS 
ver.21. An α-level of <.05 was used to indicate statistical significance.
6.1.3.6 Data specifics
Due to the nature of the research questions different patient numbers were included for 
data analysis. For ETT and TT duration, all tracheostomised patients were included for 
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Group 1 and 2. For TT insertion to SV, and SV to decannulation, only patients that were 
using a SV were included. For TT to first oral intake only patients that were having oral 
intake whilst tracheostomised, were included. The patients that died with TT in-situ were 
included in statistical analysis and their data were not censored.
6.1.4 Results
6.1.4.1 Demographics and clinical characteristics
One hundred and twenty nine patients were included; 56 pre and 73 post the 
implementation of the in-line SV. The demographic and clinical characteristics of both 
groups are summarised in Table 6-1 below. There were no statistically significant 
differences between the group in terms of age, gender, diagnoses on admission or 
surgical intervention during ICU admission (p>.05). APACHE III and SOFA (days 2, 3, and 
4) scores were significantly higher (p<.05) in Group 2 when compared to the Group 1. The 
% of sepsis was significantly higher in Group 2. ICU survival rates across both groups 
were similar at 83.9% in Group 1 and 80.8% in Group 2.
Table 6-1 – Demographic and clinical characteristics  
2011 2012
(n=26) (n=73)
Age (mean, SD) 58.5- (15.5) 59 (17)
Male 40 (81.4%) 50 (68.5%)
Diagnoses on admission
CVS 34 (60.7%) 40 (54.8%)
Respiratory 15 (26.8%) 14 (19.2%)
Sepsis 6 (10.7%) 16 (21.9%)
Other 
a
1 (1.8%) 3 (4.1%)
Surgery during ICU stay (% within group)
b
CVS 33 (97.1%) 35 (87.5%)
Thoracic 8 (53.3%) 7 (50%)
Sepsis 5 (83.3%) 13 (81.3%)
Other 1 (100%) 2 (66.7%)
APACHE III [mean (SD)] 71 (19.9) 83
c
(30.2)
SOFA score (mean, SD)
Day 1 8 (2.7) 9 (3.3)
Day 2 8 (2.2) 9
c
(3.6)
Day 3 7 (2.6) 9
c
(3.9)
Day 4 7 (2.6) 8
c
(3.8)
a 
includes patients with gastrointestinal and neurological diagnoses
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b
most common interventions across all Dx groups included cath lab, valve surgery, reopen, thoracotomy 
and laparotomy
c
p<.05 vs 2011 group
CVS – cardiovascular system; ICU – intensive care unit; APACHE III – acute physiology and chronic health 
evaluation; SOFA – sequential organ failure assessment
6.1.4.2 ETT and tracheostomy outcomes
There was no significant difference between groups with respect to ETT duration and days 
from TT insertion to decannulation (p>.05), with durations of 6 and 14 days respectively 
(see Table 6-2). There were significant differences between groups in terms of time from 
insertion of TT to first use of SV (p<.05) and time from SV to decannulation (p<.05). On 
average the introduction of SVs occurred 9 days earlier in Group 2 as compared to those 
in Group 1. 
Table 6-2 - ETT and tracheostomy outcomes
2011
mean (SD) n (%
a
)
2012 
mean SD n (%
a
) p value
ETT duration(days) 6 (4.5) 56 (100%) 6 (4) 73 (100%) 0.96
TT duration(days) 14 (13.2) 56 (100%) 14 (10.9) 73 (100%) 0.47
TT insertion to SV(days) 18 (21.3) 9 (16%) 9 (7.3) 42 (57.5%) 0.02
SV to decannulation(days) 1 (0.9) 9 (16%) 8 (8.3) 42 (57.5%) 0.001
TT to first oral intake(days) 6 (5.3) 39 (69.6%) 7 (6.8) 59 (80.8%) 0.40
a 
% of tracheostomised patients
ETT=endotracheal tube; TT=tracheostomy tube; SV=speaking valve
6.1.4.3 Communication
The number of patients with a tracheostomy using a SV of any type was significantly 
higher after the introduction of the in-line SVs, 42 in 2012 compared to 9 in 2011 (p<.05). 
Patients in Group 2 had access to verbal communication (SV to decannulation time) for a 
significantly longer period (8 days) than Group 1 (1 day). 
The use of SVs (not in-line SVs) for all nine Group 1 patients commenced when they were 
on low flow oxygen or room air via tracheostomy. The introduction of in-line SVs to the 
ICU resulted in a more variable practice in terms of ventilator status at the time an SV was 
introduced. Descriptive analysis revealed that 4 patients commenced using a SV on 
synchronous intermittent mandatory ventilation (SIMV); 11 patients on PSV; 20 on high-
flow tracheostomy piece (HFTP – as defined by >30L/min of humidified airflow through 
tracheostomy in our ICU) and 7 on low-flow oxygen.
89
Of the tracheostomised patients that did not survive ICU in 2011, none were able to 
verbally communicate during their ICU stay. In 2012, five tracheostomised patients out of 
14 that died had a chance to verbally communicate before dying. 
6.1.4.4 Swallowing
Group comparisons of time to first oral intake revealed no significant differences between 
the two groups (Table 6-2). The need for modification of fluids was less frequent post the 
introduction of in-line SV. In Group 2, 74% of patients were drinking fluids of any 
consistency as compared to 68% in Group 1. The majority of patients in both groups 
commenced oral intake of fluids on thin fluids. Interestingly, Group 1 patients were more 
likely to be on extremely thick fluids as compared to Group 2 patients (12.5%;4%). All 
tracheostomised patients in 2011 commenced oral intake with their tracheostomy cuffs 
inflated. In 2012, 42% of patients commenced oral intake with the tracheostomy cuffs 
deflated.
6.1.5 Discussion
There has been an increase in the number of tracheostomised patients [169] in ICUs due 
to the improved safety and training for percutaneous tracheotomies and some evidence 
for benefits of early tracheostomy [170]. This means that there is an increasing number of 
patients potentially able to verbally communicate whilst mechanically ventilated and 
awake. Despite clinical concerns that SVs may affect patient outcomes such as ventilation 
duration and time to decannulation the current study found that in-line SVs did not 
negatively impact on duration of mechanical ventilation and led to a significant increase in 
time where verbal communication was possible. No adverse events were reported. 
Despite the patients in Group 2 having higher APACHE III and SOFA scores, the average 
time to decannulation did not change with the introduction of the in-line SV. Because of 
such a disparate group of critically ill patients, more data are needed to investigate if early 
use of SVs could in fact facilitate weaning from mechanical ventilation. Our data indicate 
that SVs are not deleterious to weaning from mechanical ventilation. 
Little is known about the effects of SV on patients’ respiratory mechanics. Physiological 
studies are needed to better understand respiratory mechanics and determine the optimal 
methods for successful and beneficial use of in-line SVs in the mechanically ventilated 
ICU population. Our group and others have reported on EIT [104]. It provides real time 
assessment with no risk of ionising radiation [171], and could be utilised to look at 
respiratory mechanics in patients with SVs also.
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There have been numerous studies looking at communication interactions between the 
patient and nursing staff, and studies where patients have been asked to retrospectively 
rate their success with different modes of communication whilst mechanically ventilated in 
the ICU [6-9, 119, 172]. However, little has been reported on success of communication in 
ICU patients comparing patients’ and nursing staff perspectives. The effect that reduced 
level of alertness, delirium and not being able to verbally communicate has on the quality 
and success of health communication for patients and in nursing staff looking after their 
patients is also relatively unknown. The ability to verbally communicate whilst still 
mechanically ventilated could also have a positive effect on the much spoken about ‘post-
intensive care syndrome’ (PICS), which in turn would require further investigation [173].
The introduction of in-line SVs into our ICU has changed practice significantly. SVs are 
now being used as a communication option / weaning tool for tracheostomised patients. It 
seemed to be a mere step before decannulation with the previously used SVs that were 
unable to be fit in-line with the ventilator tubing. These SVs were therefore only used with 
limited number of patients that were nearing decannulation, and did not need more than a 
few litres of oxygen via their TTs for respiratory support. Use of in-line SVs in our ICU has 
led to the practice where the patients are assessed for suitability to use a SV as soon as
their haemodynamics are stable: they are awake and attempting to communicate, 
regardless of their ventilation needs. 
The fact that there were no adverse events reported with the significant increase in the 
use of SVs has a lot to contribute to ongoing and frequent in-servicing of staff to ensure 
patient safety. Based on our experience, SP presence in the ICU and an open referral 
system for tracheostomised patients have had a positive effect on improved 
communication options and earlier oral intake for patients. SP was directly involved with 
the majority of the tracheostomised patients in the ICU across the two years with the 
exception of a few that never fully regained consciousness, and died in ICU.
6.1.5.1 Limitations of the study
It is an observational ‘before and after’ study at a single centre. The results in 
cardiothoracic patients in this sample may not be generalisable to other settings such as 
those with neurological diagnoses. Due to the small sample size we were unable to 
compare the outcomes of similar patients across the two groups, which would have 
allowed us to obtain more accurate data on the potential impact of in-line SVs on time to 
decannulation. 
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6.1.6 Conclusion
The use of in-line SVs in tracheostomised patients enables a return to verbal 
communication sooner, accompanied by improved oral intake. However, more research is 
needed to determine the efficacy of SVs in the weaning process of tracheostomised 
mechanically ventilated ICU patients. These results demonstrate that the ability of the 
patient to communicate can be improved substantially, with no adverse effect on 
ventilation times. If our data on SVs is replicated in other centers it would suggest that 
SVs can be used more widely to improve the quality and comfort of care of the critically ill
patient.  
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6.2 Speaking valves as part of standard care with tracheostomised mechanically 
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6.2.1 Rationale and significance
No change occurs overnight, especially in the critical care environment. Whilst in-line SV 
use at TPCH ICU commenced in 2012, widespread use and routine practice took time to 
develop. It was decided to investigate similar data from the subsequent two years once SV 
use had become a part of routine practice at TPCH ICU. Although no incidences had 
occurred, the aim was to investigate whether patient outcomes in ICU had changed over 
time, with safety being of utmost importance.
6.2.2 Background
We recently reported (see section 6.1) on tracheostomy related outcomes comparing two 
consecutive years before (2011) and after (2012) the introduction of an in-line 
tracheostomy SV into practice in a primarily cardio-thoracic ICU [107]. Our results 
indicated a significantly earlier return to verbal communication for tracheostomised 
patients after the introduction of an in-line SV without effecting ventilator weaning or 
decannulation time.  
The practice of using SVs in our ICU has continued to increase and is now part of 
standard care with tracheostomised mechanically ventilated patients. Following ethics 
approval we collated and analysed similar outcomes of all tracheostomised patients in ICU 
for the following two years (2013 and 2014). Our aim was to assess whether clinical 
uptake had continued after the initial “honeymoon” phase associated with the original 
research. Equally, as our process matured, we looked to assess how tracheostomy 
outcomes had changed. 
6.2.3 Results
There were 274 tracheostomised patients in our ICU across the relevant four years (2011-
2014). The vast majority of tracheostomies (98.5% in 2013, 96.1% in 2014) were 
performed percutaneously in ICU. Patient demographics, disease severity, ICU survival, 
intubation and tracheostomy specific outcomes are collated in Table 6-3. There were no 
significant changes in diagnoses groups compared to the previous two years, majority of 
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patients admitted with cardiovascular or respiratory disease. There has been a significant 
reduction in the average number of days from TT insertion to return to verbal 
communication since the previous study – time to return of verbal communication has 
reduced three-fold since introducing the in-line SVs into the ICU, on average now being 6 
days post tracheostomy insertion (p<0.001). Analyses of the patients’ ventilation needs 
revealed a notable increase of patients with whom SV use was initiated whilst still 
mechanically ventilated (70% of SV users in 2014, 34%, 37% and 0% in 2013, 2012 and 
2011 respectively, p<0.001). Overall, ~75% of all our tracheostomised patients are now 
communicating verbally. There was no change in time to return of oral intake between the 
two studies. This improvement in ability to speak has not been associated with any 
deterioration of any measurable ventilatory or respiratory outcomes. 
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Table 6-3 – Results 
Demographic and clinical           2011       2012 2013 2014                          
characteristics (n=56)                              (n=73) (n=68) (n=77)         p
b
Age (mean, SD) 58.5 (15.5)       59 (17) 59 (16) 57 (17)
Male 40 (81.4%)       50 (68.5%) 43 (63.2%) 49 (63.6%)
APACHE III [mean (SD)] 71 (19.9)       83
c
(30.2) 71 (21.3) 81 (28.4)     =0.029
SOFA score (mean, SD)
Day 1 8 (2.7)       9   (3.3) 8 (2.6) 9 (3)     
Day 2 8 (2.2)       9
c
(3.6) 8 (2.6) 9 (3.2)     =0.035
Day 3 7 (2.6)       9
c
(3.9) 8 (2.9) 9 (2.9)     =0.022
Day 4 7 (2.6)       8
c
(3.8) 8 (3.3) 8 (2.8)     =0.012
Survived ICU
a
83.9%       80.8% 88.2% 77.9%
ETT and tracheostomy
outcomes mean (SD) %
a
      mean (SD)    %
a
mean (SD) %
a
mean (SD) %
ETT duration (days) 6 (4.5) 100%       6 (4)   100% 5 (4.2) 100% 6.5 (5) 100%
TT duration (days) 14 (13.2) 100%       14 (10.9) 
   
100% 13 (9.1) 100% 13.5 (16.8) 100%
TT insertion to SV (days) 18 (21.3) 16%       9 (7.3)
   
57.5% 8 (7) 77.9% 6 (5.6) 74%         <0.001
SV to decannulation (days) 1 (0.9) 16%       8 (8.3)
   
57.5% 6 (4.9) 77.9% 9 (16.9) 74%     =0.048
TT to first oral intake (days) 6 (5.3) 69.6%       7 (6.8) 
   
80.8% 9 (7.9) 73.5% 6 (7) 72.7%
a 
% of tracheostomised patients
b 
p-value comparing 2011 and 2014 
APACHE III – acute physiology and chronic health evaluation; SOFA – sequential organ failure assessment; ETT=endotracheal tube; TT=tracheostomy tube; 
SV=speaking valve
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6.2.4 Discussion and Conclusions
There is an ongoing debate in literature regarding outcomes, safety and efficacy of early 
versus late tracheostomy in patients requiring prolonged mechanical ventilation [16]. 
Whilst there are still proponents and opponents of early tracheostomy one absolute 
advantage is the ability for patients who still require mechanical ventilation to be able to 
speak. Our data presented here show that clinical uptake of this technique and safety 
associated with it continues to increase. Without a TT, mechanically ventilated patients 
would not be eating and drinking and they would be unable to speak. Voicelessness may 
have other disadvantages such as agitation and confusion due to their inability to 
communicate their pain, distress and wishes. There are accumulating data concerning the 
benefits of early rehabilitation in ICU [174, 175]. Having a TT as opposed to an ETT is the 
only way to restore verbal communication and safe oral intake in our mechanically 
ventilated patient population. Certainly, there remains the need for physiological studies 
using SVs and further similar studies with different patient populations to be able to 
confirm the safety and benefits of SVs.
Use of SVs as part of standard care with our tracheostomised mechanically ventilated 
patients in ICU for the last 3.5 years has resulted in a situation where having a non-verbal 
tracheostomised patient is an exception. It has somewhat confused our weaning practice, 
with patients often using a SV all day whether still on ventilator or doing trials off the 
ventilator. Data indicating increased EELVs and improved diaphragm mobility during SV 
use [176] further confirms potential benefits of the valve. This, however, raises some 
questions about rehabilitation practices – what is the physiological ‘sweet spot’ for 
diaphragm recovery? Are we exercising some of our patients too much by having them 
use a SV all day whilst still mechanically ventilated? More research is needed to clarify the 
role of SVs in weaning.  
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Chapter 7 Speaking Valves and Communication Success in the ICU
7.0 Rationale and significance
As summarised in Chapter 2, use of SVs is one of the best ways to ensure successful 
communication for tracheostomised ICU patients.  In Chapter 6 it was explained that the 
uptake of SVs at TPCH ICU has been excellent, leading to a significantly earlier return to 
verbal communication for tracheostomised patients. Data in Chapters 3 and 4 support the 
respiratory safety of SV use, whilst Chapter 5 explains the extra caution that needs to be 
taken when introducing SVs to specific patient groups. These findings, however, do not 
capture the benefits of using a SV to improve communication.
It is easy to assume that communication success must improve significantly following the 
restoration of the patient’s ability to talk. ICU patients, however, are often very weak, which 
makes talking a challenge despite the restoration of airflow via their glottis. At the same 
time, some patients’ ability to “mouth” their message is excellent, making non-verbal 
communication also effective. It is therefore important to measure the difference, if any, in 
communication success with and without SV use. Communication is a two-way process. 
Successful communication needs both the communicator and the communication partner 
to succeed in delivering and capturing the message. For these reasons the present study 
measured the patients’ success with health communication, asking both the patients and 
nursing staff to rate the patients’ success before SV use, and again during SV use on a 
visual analog scale, addressing the third aim of this thesis. The specific SV used in this 
study is a Passy Muir SV (PMV007, Passy Muir Inc., California, USA).
The results of this study were partially presented at the 2015 ATS conference in Denver, 
Colorado and have been published in an abstract format. The results have also been 
presented at numerous other local, national and international presentations listed in
Presentations during candidature on page vii. Sections, tables and graphs have been 
numbered, and abbreviations continued to align with the rest of the thesis document.
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7.1 Introduction
Communication in ICU can be challenging for both the patients and the ICU team. It is 
especially difficult for mechanically ventilated patients that often cannot use their voice due 
to air bypassing their larynx. Non-verbal communication is often not specific enough, and 
its success is frequently impacted by ICU acquired weakness [88].
Studies to date have examined how patients and ICU physicians, nursing staff and families 
perceive communicative interactions, including communication during clinical handover 
practices and delivery of care [91-95]. Magnus [96] studied the perceived difficulty of 
communication from the perspectives of recent ICU patients and multidisciplinary staff. 
The study included 8 patients and 9 staff across 5 ICUs and involved a semi-structured 
interview. Magnus found that patients perceived the communication difficulties to be 
greater compared to staff ratings. Some of the study participants had experienced a period 
of voicelessness throughout their ICU stay.
To date, there are no published data comparing communication success as between the 
period of voicelessness and the period with restored communication in a similar situation 
(i.e., being voiceless and then using a SV in ICU). Assumptions are often made that staff 
have understood the message conveyed by a patient, however the success of the 
communication interaction in terms of accuracy of information conveyed and 
communication partner satisfaction have not been reported.
There are tools that are designed to measure communicative effectiveness in patients with 
language difficulties, such as the Communicative Effectiveness Index. Lomas et al [177]
designed and validated this tool for people with aphasia. As it is very specific to day-to-day 
life and situations experienced by people with aphasia, it was found not to be suitable for 
implementation in an ICU setting.  On the other hand, there are tools that have been 
effectively used to measure quality of life in ICU [178] which also address communication, 
among other parameters. Without having communication at the forefront, however, this 
tool is less susceptible to changes that SV use may bring and it would be difficult to 
measure communication success specifically. With no suitable existing tools, new 5 and 6 
item questionnaires were developed as part of this study. These enabled the assessment 
of patient communication success with and without a SV from the perspectives of both 
patients and nursing staff.
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7.2 Methods
7.2.1 Setting
A prospective study in a cardio-thoracic ICU at a metropolitan teaching hospital was 
conducted to assess the success of health communication for patients that are 
tracheostomised and weaning off mechanical ventilation.
7.2.2 Sample
Following approval from the local ethics committee, participants were screened for 
eligibility. Twenty-five consecutive ICU patients that were using a SV and managing well 
with basic communication were recruited to the study. Informed consent was gained from 
the patients or their next of kin. Fifty-two nurses that were caring for these patients were 
also recruited following informed consent.
7.2.3 Communication questionnaire
Due to the absence of any suitable existing tools, communication success questionnaires 
were designed for this study (see Appendices 2 and 3). These asked both participant 
groups to rate the patients’ success with ICU specific communication on a 10cm visual 
analogue scale. A score of 0 meant profound communication difficulties; a score of 10 
indicated no communication difficulties. The types of questions asked were decided upon 
following numerous discussions with ICU staff and tracheostomised patients throughout 
the months preceding, ensuring the most important topics for these type of patients were 
covered.
The patient questionnaire was designed to address different underlying mechanisms for 
communication in the ICU, such as saying something quickly, or giving detailed 
information. For example, in order to be able to let the nursing staff know about pain a
patient needs to be able to give detailed information, and in some instances must be able 
to say it quickly. The difference in communication success with the healthcare team and 
the patients’ family was also queried. The nursing staff questionnaire was designed to 
assess the patients’ success in communicating information and needs that are often acute 
whilst in ICU (such as pain, allergies, past medical history). The nurses were also asked to 
rate how big of an obstacle communication was for them in looking after the patient.
7.2.3.1 Patients
The patients were asked to fill out their 6-item questionnaire twice. Initial administration of 
the questionnaire took place when they were voiceless. Patients subsequently completed 
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the questionnaire when using a SV. Initial and second administration occasionally took 
place on the same day, and in some cases up to two days apart. The nursing staff was 
blinded to the patients’ ratings, and vice versa. In cases where the patient’s fine motor 
skills did not enable independent administration of the questionnaire, the patient pointed 
out the appropriate spot on the visual analogue scale and this was marked on the scale by 
the primary author, with further confirmation provided by the patient regarding accuracy.
7.2.3.2 Nursing staff
Nursing staff were asked to fill out a similar 5-item questionnaire twice, first when the 
patient they were caring for was voiceless, then subsequently when the patient was still 
tracheostomised but able to use their voice with a SV in-situ. In cases where a nurse had 
only been looking after the patient in one condition only (i.e., with a SV), a different nurse 
was approached to fill out the questionnaire about the opposite condition. At least two 
nurses were recruited per every patient. Some nurses filled out the questionnaire about 
several patients. 
7.2.4 Data analysis
All data were collated in an Excel spreadsheet, and mean values calculated. To calculate 
the average success score with communication, all but the last question in the 
questionnaire were included for both patients and the nursing staff. Paired t-tests were
used to calculate p values and SD, using SPSS. Data were not tested for normality.
7.3 Results
Twenty-five tracheostomised patients (52% male, average age 60.1) and 52 nurses (81%
female, average 10.5 years of experience in ICU) were approached to fill out the 
questionnaire. Twenty pre-SV and 19 with SV questionnaires were successfully filled out 
by 20 patients in total, 45 pre-SV and 51 with SV questionnaires were filled out by 52
nursing staff in total (135 questionnaires in total). Each patient had 2-4 nurses filling out 
the questionnaires about their communication success.
Patients rated the importance of being able to communicate with others (Q6) as very high 
(see Graph 7-1 below). The scores did not change significantly (p=0.102) once the 
patients were using a SV, with the importance of communication remaining very high
(8.8/10 to 9.4/10). Prior to SV use, patients rated the effectiveness of communicative 
interactions poorly (average of 2.2/10) while nursing staff rated the patients’ 
communication success as average (average of 4.95/10). A significant improvement in 
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communication success after SV implementation was observed (p<0.001), with improved 
ratings from both patients and nurses looking after them. See Graphs 7-1 and 7-2 below.
7.3.1 Patients
Similar scores were attributed to patients’ perception of how well their families (Q5) and
healthcare team (Q4) could understand them when they were voiceless (2.9/10), and once 
they were using a SV (8.9/10 for healthcare team and 8.7/10 for family). The most difficult
communication tasks for the patient while limited to non-verbal communication were:
asking questions (Q1); giving detailed information (Q2), and saying something quickly 
(Q3). All of these tasks improved significantly (p<0.001 for all) with the use of SV. See
Graph 7-1 below.
Graph 7-1 – Patients’ ratings of success with communication before and after the 
implementation of SV
Q1=How successful are you in asking something quickly?; Q2= How successful are you in 
giving detailed information?; Q3= How successful are you in saying something quickly?; 
Q4=Overall, how successful are you in getting your message across to the healthcare 
team?; Q5= Overall, how successful are you in getting your message across to family and 
friends?; Q6=Overall how important is being able to communicate to others for you?
7.3.2 Nurses
Overall, the nursing staff reported that communication was a barrier in looking after their
patients (Q5). Understanding patients’ needs, wants and wishes (Q4) was scored low 
(4.9/10) for the voiceless patients. Once the patients were using a SV, this increased to 
8.9/10. The nurses indicated that they were able to understand if their patient had pain or 
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discomfort relatively well even when the patients were voiceless (6.2/10), the rating 
significantly increasing with SV use (9.1/10, p <0.001). Nursing staff felt that it was more 
challenging to get detailed information from patients when they were not able to use their 
voice (with relevant information including details on past medical history and allergies, and 
the presence of confusion or communication difficulties - Q2 and Q3, respectively). This 
improved once the SV was in use (p <0.001). See Graph 7-2 below.
Graph 7-2 – Nurses’ ratings of patient’s success with communication before and after the 
implementation of SV
Q1=How well are you able to understand if your patient has any pain/discomfort?; 
Q2=How well are you able to get information from your patient about their previous 
medical history/allergies?; Q3=How well are you able to assess presence of confusion 
and/or communication difficulties in your patient?; Q4=How well do you feel you 
understand the patient and their needs/wants/wishes?; Q5=How big of an obstacle is the 
patient’s communicative ability for you in looking after them?
7.3.3 Case examples 
There were 3 patients who rated their communication success above 5/10 (average 5.9) 
prior to SV use, and close to maximum once they were using a SV. For these patients the 
average communication success as rated by nursing staff was also high (7.2/10), reaching 
close to maximum once the patients were verbally communicating. These patients were 
noted to have good oro-motor and upper limb movement and they were able to 
communicate with moderate success by mouthing or writing their message when 
voiceless.
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There were also 3 patients that rated their communication very poorly (0; 3.4 and 0.4) 
when they were voiceless with an improvement to maximum of 10 by all three once they 
were talking. Nursing staff scores for these patients also indicated a similar jump (pre SV –
3.4; 1; 4.3), with scores reaching 9.3 on average once the patients were talking. 
There were 4 patients that rated their communication success below 7.5 (5.6; 6.3; 7.1 and 
7.3) even once they had a SV in-situ. Nursing ratings for most of these patients’
communication success were high (8.9; 8.9; 8.4 and 6.9 respectively). Numerous patients 
rated their communication success very poorly, with nursing staff scores remaining 
moderate. The last two examples create a discrepancy in the overall success rate scores 
when the patients were voiceless.
7.4 Discussion
SVs increased success with health communication in general. The magnitude of change in 
communication success with the introduction of the SV was noticeably greater in the 
patients’ responses (6.2-7.2 point improvement with SV) than it was for nursing staff (2.9-
5.1 point improvement with SV). The ratings of success with communication between 
nurse and patient prior to SV use were clearly disparate, with nurses perceiving 
communicative interactions to be more successful than patients. This could perhaps be 
partially explained by the nurses being used to similar situations with voiceless patients, 
influencing their ratings, whereas being voiceless in the ICU is usually the first such 
experience for the patient, potentially increasing their dissatisfaction and frustration. At the 
same time, the patient is more likely to have a better idea of the communicative success 
as the holder of original needs, wants and questions that are unable to be passed on to 
the nurse looking after them. Whatever the cause of this asymmetry, the situation may 
lead to increased frustration for the patient with the nurse thinking they have understood 
the patient prematurely. The conversation may therefore finish with the intended 
thoughts/requests from patient yet to be conveyed. This may further explain the reported 
patient frustration, anxiety and stress levels associated with voicelessness [11, 24]. 
The case examples indicate that patients fell into 2 different groups when they were 
voiceless: (1) patients that were able to successfully communicate by alternative means, 
whether ‘mouthing’ or using AAC devices, and (2) patients that experienced no 
communicative success whilst voiceless. The success of non-verbal communication is 
often dependent not only on the patients’ level of alertness, their upper limb dexterity and 
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oro-motor abilities, but also their willingness to accept and use an AAC device. For many 
of these patients, communication success was restored to a near maximum level with the 
use of SV. Equally, these cases highlight the reality that communication does not always 
become fully successful with the return of the ability to use one’s voice. Many patients 
continue to experience notable difficulty when saying something quickly (Q3), even once 
they are able to talk. Some patients’ overall success scores remain low despite having 
their voice back. Clinically, this is often due to critical illness weakness contributing to 
reduced intelligibility of speech. This emphasises the need for healthcare staff to be extra 
vigilant and give the patients more time during interactions. 
Another important factor in determining the success of communicating a message is the 
duration of communication interaction. Leathart [97] monitored nursing staff and patient 
interactions during usual care of a ventilated patient and found that the average interaction 
only lasted <30 seconds and the overall time spent communicating with a ventilated 
patient was generally very low. Although, not directly measured as part of this study, 
informal observations in ICU suggest that duration of time spent on communicating with a 
patient increases significantly once the patient is able to actively engage in conversation. 
This would also lead to more information being exchanged, and communicative success 
hopefully being greater. Further research into this area is warranted.
Overall, the introduction of the SV significantly increased the success with communication 
for tracheostomised mechanically ventilated patients from both the patient and nurse 
perspectives. Having a voice made it significantly easier for the patients to express 
themselves in a more comprehensive way. 
7.4.1 Limitations of the study
Due to specific questionnaires/scales not being available in the literature, original non-
validated questionnaires needed to be used for this study. Best efforts were made to 
ensure the questionnaires included the most relevant topics for the tracheostomised 
patients and the nurses caring for them. The two questionnaires differed slightly for the 
patients and nursing staff. This makes the results somewhat less comparative. 
The participants at times appeared to misinterpret the last question in the nursing staff 
questionnaire, with clarifying questions asked from the main author. Rewording of this 
would need to be considered if the questionnaires were to be used again for similar 
studies.
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7.5 Conclusion
Healthcare staff may not be as successful at understanding their non-verbal patients as 
they believe, and may underestimate the communication difficulties experienced by 
patients.  SV use with tracheostomised patients has the potential to improve patient 
involvement in their healthcare and reduce misinterpretations of meaning and patient 
frustration. 
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Chapter 8 Summary, Discussion and Conclusions
8.1 Summary
This thesis consists of 8 chapters. Four of these chapters include published [107, 108, 
120], accepted or submitted manuscripts [137, 179] in peer-reviewed journals. Manuscripts 
have been included in pre-publication format and numbering of tables, graphs and figures 
modified to align with the rest of the thesis. 
To address the three aims of the thesis, 5 hypotheses were generated and five studies 
conducted. The main aim of the thesis was to investigate the effect of SV use on 
respiratory mechanics to determine whether these should be used in-line with mechanical 
ventilation of tracheostomised patients. The first hypothesis ‘Use of SVs in 
tracheostomised patients weaning from mechanical ventilation causes an increase in 
EELV’ is addressed in Chapter 3. That chapter contains an overview of a prospective 
observational study with 20 consecutive tracheostomised ICU patients weaning from 
mechanical ventilation and using a SV. The findings suggest that there is a significant 
increase in EELI / EELVs during and post SV use, as measured by EIT. Alongside the 
increase in EELI, the patients showed reduced RR and EtCO2, and unchanged SpO2
[120]. These findings provided evidence that concerns over the detrimental effect of SV 
use on lung recruitment may be unfounded, contributing to a wider rollout of SV use in 
TPCH ICU that is presented in Chapter 6.
The second hypothesis addressing the first aim was ‘SV use in tracheostomised patients 
weaning from mechanical ventilation causes a redistribution of ventilation into different 
parts of the lung’. To investigate the physiology behind the significant increase in EELI as 
described in Chapter 3, EIT data were further analysed to exclude any potential 
deleterious effects to weaning patients off mechanical ventilation. The first part of Chapter 
4 presents data on ventilation distribution and concludes that SV use does not cause any 
significant shifts in ventilation, with the increase in EELI being uniform across anterior-
posterior and left-right sections of the lung. Additionally, newer EIT variables such as TVar, 
VSA and RVD are reported suggesting potential for recruitment and excluding 
hyperinflation as a result of increased EELI. The second part of Chapter 4 presents data 
on A:C ratio with SV use. The results show increased abdominal activity during SV use 
suggesting increased diaphragm activity. The findings in Chapter 4 further ensure safety of 
SV use in the cardio-thoracic ICU population [137].
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Additionally, a case study is presented in Chapter 5. This chapter summarises a COPD 
patient case in whom a SV caused an increase in EELI, similarly to studies described in 
Chapters 3 and 4. However, in this instance the SV use caused lung hyperinflation, 
impacting on gas exchange and resulting in significant desaturation [179]. Whilst SVs are 
generally safe, this case highlights the need to individually assess patients for suitability of 
SV use, taking into consideration their underlying respiratory condition. Equally, it 
highlights the importance of close observation during initiation of SV use, and the SVs’ 
potential in actually assisting in covert diagnoses, as occurred in this case.
The second aim of this thesis was to assess the effect of introduction of SVs into a 
cardiothoracic ICU on tracheostomy specific outcomes in patients. Two hypotheses were 
generated to address this aim: (1) routine SV use in a cardio-thoracic ICU does not have a 
deleterious effect on ICU and SP outcomes for tracheostomised patients, and (2) routine 
SV use in a cardio-thoracic ICU facilitates an earlier return of vocal function for 
tracheostomised patients. Two publications presented in Chapter 6 summarise
tracheostomy and SP specific patient outcomes for all tracheostomised patients (n=274) 
admitted to TPCH ICU from 2011-2014. The results highlight a 3-fold decrease in the time 
taken from TT insertion to first use of SV across these 4 years (6 days on average in 2014, 
and 18 days in 2011). The majority of tracheostomised patients (75%) were reported to 
use a SV in 2014 (70% starting SV use in-line with mechanical ventilation) as compared to 
16% in 2011 (0% using SV in-line with mechanical ventilation). Such a significant surge in 
SV use had no negative impact on the average ventilation time or time to decannulation
[107, 108].  
The third aim of this thesis was to further clarify the effect of SVs on success with health-
related communication for ICU patients. It was hypothesised that SV use would result in 
increased success with health-related communication reported by both the patients and 
nursing staff. Chapter 7 focuses on 20 consecutive ICU patients using a SV and the 52 
nurses looking after them. As part of the study both the patients and the nurses were 
asked to fill out a simple 5 and a 6-item visual analogue scale questionnaire before and 
during SV use. The results indicate significantly improved success with health related 
communication when the patients were using a SV as reported by both groups. 
Interestingly, when the patients were voiceless, the nurses rated the patients’ success with 
communication significantly higher than the patients’ own rating. As there is a mismatch, 
this may explain some of the frustration experienced by patients that are left voiceless that 
has been previously reported in the literature [11, 24]. 
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8.2 Clinical implications
Whilst these studies occurred in one hospital, the ramifications of this work have been 
widespread, with changes occurring across Australia, the USA and Europe, as reported to 
me by my international colleagues. This thesis provides clinicians with fundamental data 
on the impact of SV use on respiratory mechanics, patient outcomes associated with ICU 
and tracheostomy, and patients’ success with health related communication whilst 
tracheostomised and in ICU. All of the data presented are encouraging towards 
widespread SV use in the mechanically ventilated, tracheostomised cardio-thoracic ICU 
population.
Locally, the findings of this research project have significantly changed practice. From 0% 
of ventilated TT patients talking in 2011, 75% of ventilated patients were using a SV in 
2014 [108]. SV use is now routine practice, and questions are raised by the ICU team
whenever there is an occasional patient that is not talking. The implementation of SVs has 
improved communication in the ICU. This has facilitated patients becoming active 
participants rather than passive recipients of care. ‘SV gives me back my autonomy and 
makes me feel like part of the human race again’, was a comment from one long-stay 
patient in ICU. The ICU has progressed to using SVs with patients that are critically unwell, 
including patients on extracorporeal circuits, cardiac transplants and with open chests 
[134]. These patients would have previously been deeply sedated, and therefore passive 
recipients of care. With SV use, patients report feeling empowered, able to maintain focus 
and often negotiate therapy goals with the multidisciplinary team. This allows for earlier 
and more active rehabilitation. Reports from the patients and the whole multidisciplinary 
team reveal the significantly improved quality of life in the ICU for these patients that were 
previously left voiceless.
This thesis is an example of how research into important clinical vacuums of data can 
translate into change and improved outcomes. 
8.2.1 Barriers to implementation
(Within Australia)
Speech Pathologists are the main facilitators of patient communication. Use of SVs with 
patients has therefore always been a SP role. Assessing someone’s ability to manage 
their oral secretions and upper airway patency for successful cuff deflation and suitability 
for SV trials is part of routine SP practice. The majority of SPs currently have inadequate 
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knowledge of respiratory physiology and ventilatory management to independently control 
the safe implementation of SV with tracheostomised mechanically ventilated patients. 
There are ICUs where physiotherapists have advanced skills and are more involved with 
altering ventilatory settings, however, in general, Allied Health do not have active input in 
ventilatory weaning in Australia. The role for nursing staff in weaning also varies 
significantly across ICUs. In the difficult to wean patients, generally only the intensivists 
determine weaning strategies. A multitude of clinical and non-clinical commitments mean 
that intensivists do not have the ability to be available at all times for the speech 
pathologists when using the SV. Upskilling of senior speech pathologists in areas of 
physiology and understanding of mechanical ventilation will greatly enhance their ability to 
lead SV use with the mechanically ventilated ICU population. Augmenting the knowledge 
base within the SP craft group further advances the importance of SP and potential 
contributions to the ICU in relation to ventilated patients. When speech pathologists can 
comprehensively and fully understand and explain the use of SVs in mechanical ventilation 
and their effect on lung mechanics, their key role in the multidisciplinary ICU team will be 
further cemented. There is an acute need to up-skill Allied Health staff in Australia to be 
able to actively implement SV use. The specific knowledge that respiratory therapists 
possess in the US is desperately needed for Allied Health staff working in the ICUs in 
Australia. 
8.3 Limitations
One limitation of this thesis is the specific patient cohort of ICU patients with primarily 
cardio-respiratory disease. Despite this being the most suitable cohort to answer the key
clinical and research questions around respiratory physiology with and without SV use, 
extrapolation of the data to other clinical populations should be undertaken with due 
caution. 
Some results including diaphragmatic function and airway pressure data presented are 
weak due to limitations with available measuring techniques, as discussed in Chapters 3 
and 4. Although EtCO2 monitoring was successful in the study described in Chapter 3, 
TcCO2 could be considered, as an attractive non-invasive option for future studies. Cost 
and some limitations with operating time may limit its use in clinical practice. TcCO2
monitoring was not used as part of this study due to lack of availability of the necessary 
equipment at the time.
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A separate group of patients receiving volume-controlled ventilation would have added 
significant value to Chapters 3 and 4 as ventilation mode may have a significant impact on 
EELV and ventilation distribution. Inclusion of such a group was not feasible due to the 
very limited patient numbers in whom volume-controlled ventilation was still being used 
whilst awake and attempting to communicate. This would have been more easily achieved 
in countries such as USA where volume-controlled ventilation is often preferred to 
pressure-controlled ventilation. 
The study was conducted with patients supported on Puritan-Bennett 840 ventilators. 
Whilst the majority of ventilators work on similar principles, there are many subtle 
differences between models and brands. One of the important aspects may be the location 
and timing of set PEEP delivery. As SV use does not allow for exhalation back towards the 
ventilator, it may lead to the ventilator not delivering any PEEP during SV use, depending 
on the exact location of PEEP triggering. Another aspect that impacts PEEP delivery is the
patient’s ability to close their glottis during inhalation. Neither of these variables could be 
controlled for or precisely measured as part of this study.
Another aspect to potentially have a significant impact on respiratory physiology with SV 
use is the TT to trachea ratio. This will always be variable between patients, and aside 
from ensuring there was sufficient space for the patient to comfortably breathe around the 
deflated cuff it could not be measured as part of this study. A different TT to trachea ratio 
would mean variable resistance to air moving around the TT in all patients (in addition to 
an already variable physiological PEEP), which may potentially also affect EELI and 
ventilation distribution.
8.4 Future directions
There are numerous observations that were made throughout the implementation of 
widespread SV use that will lead to future studies. Being able to speak is just one aspect 
of optimising care for these patients, but being an active participant in their care is equally 
if not more important. This subjective concept is difficult to quantify, and reports thus far 
are purely based on patients’ comments. 
Also, personal observation indicates that once long-stay patients are able to speak again, 
staff tend to re-orientate them much more actively. This may lead to reduced rate and 
duration of delirium, a condition known to be associated with significantly increased 
mortality and morbidity, and increased cost of care [180-182]. These observations have 
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led to a separate study on improving the diagnosis and management of delirium in our ICU 
patients.
Another common observation is that patients tend to receive less sedative drugs once they 
are talking. It may be due to the patients being able to ask questions and clarify the 
situation that often causes extreme frustration and distress [8, 23, 24] leading to agitation 
and delirium often necessitating re-sedation. This observation is now being more formally 
assessed through investigating the effect of SVs on sedative drug use.
Dr. Mary Massery theories [38, 41] on the role of glottis in postural stability and control 
were touched upon in Chapter 2. Stemming from these theories we have initiated a project 
in conjunction with the ICU physiotherapists looking at the effect of SVs on mobility and 
limb strength. 
Now that SVs are used with patients sometimes for the whole day, more research is 
necessary to look at some of the following: 
- What is the physiological ‘sweet-spot’ for diaphragm recovery – how much SV use 
is enough and when is it too much to cause muscle fatigue?  
- Are there long-term benefits of early SV use in the ICU – perhaps reduced 
incidence of PICS and improved quality of life?
- How do patients manage their oral secretions with a deflated cuff on a ventilator 
that is often set to deliver high pressures and flows?
TT size and type is commonly determined at the patient’s bedside immediately prior to 
tracheostomy, through assessment of the patient’s neck anatomy and the size of the ETT. 
As witnessed in clinical practice, occasionally the size and/or type of the chosen TT is 
incorrect, causing issues with ventilation due to cuff leak or potentially resulting in tracheal 
pressure injuries. More research is needed to investigate better ways to ensure the most 
accurate TT type and size for best TT fit and positioning. This is essential for suitable 
candidacy for SV, but more importantly for adequate ventilation and reducing the rate of 
tracheal complications during and post TT. Some work in this area has commenced 
elsewhere [183-185], but no clinically feasible options have been reported on. Preliminary 
discussions have been held locally, and the need for a potentially new design ETT and TT 
has been identified amongst other research ideas.
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Moving forward, my greatest interest remains around physiology. Several additional areas 
of future research have arisen based on clinical observations during SV use. Essential 
research into further investigating the role of larynx in breathing and other bodily functions 
is needed. The impact of SVs on cardiac physiology remains unclear – the way negative 
pressure ventilation potentially changes pressures and preload is of great interest to me. 
In addition to more specific research, the dissemination of this new knowledge is needed 
worldwide to increase SV use in ICU. A recent systematic review [88] published in a high 
impact critical care journal on communication options for ventilated ICU patients failed to 
even mention SV as an option. They opined that SVs could not be used when patients are 
still fully ventilated. There is certainly a lack of data on suitable ventilator parameters for 
SV use, however leaving SVs out of the systematic review shows how much more work 
and education is needed in the area. To contribute to this body of work, I co-authored a 
letter to the editor in response to this article [134] (also see Appendix 4) to draw readers’ 
attention to SVs as an excellent communication option for some of these patients. 
To investigate the barriers and gaps in knowledge for wider roll-out of SVs in the ventilated 
ICU population our multidisciplinary team (intensivist, physiotherapist, speech pathologist, 
nurse) is in the process of finalising a questionnaire to be distributed amongst the 
multidisciplinary staff working in Australian ICUs. 
To address the need for further knowledge on respiratory mechanics and mechanical 
ventilation for Allied Health staff, multiple multidisciplinary workshops in Australian capital 
cities have been organised for later this year, involving respiratory therapists from the US 
amongst local experts. 
8.5 Conclusions
In conclusion, my PhD thesis has explained some of the respiratory physiology behind SV 
use in tracheostomised ICU patients weaning off mechanical ventilation. The promising 
data are accompanied by the reports of significantly improved success with health 
communication for the patient. 
Recommendations from this study are not to start using EIT on every patient 
before/during/after SV use, but to rely on patient’s underlying diagnosis, bedside cardio-
respiratory monitoring and patient reports to guide clinical decision-making. 
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This research has resulted in significant change in routine clinical practice locally where all 
tracheostomised patients are now assessed for early SV use. Uptake of similar practice 
elsewhere is rapidly gaining ground, benefitting critically ill patients around the world.
My PhD has taught me to ask clinically relevant questions, find gaps in literature, and 
answer these via research. My limited research to date has helped me showcase the 
relevance and benefits of SP input with tracheostomised mechanically ventilated ICU 
patients to the multidisciplinary ICU team. This has resulted in SP being a fulltime member 
of the ICU team and automatically involved in the care of all tracheostomised patients from 
day one. I am excited about the opportunities ahead and the continuing potential to 
contribute first-hand original knowledge to the world. I am equally excited to be able to 
continue help others commence their research journeys to further increase our knowledge 
and improve healthcare.
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Appendix 2
Quality of Health Communication in ICU Questionnaire – Nursing Staff
To answer the following questions please think about the success of 
_________________________’s [insert patient name] communication attempts over 
__________________________ [researcher to indicate time] when they were/ were not 
[researcher to indicate one] using a speaking valve. 
Using the scale provided indicate through a mark on the line for each question the level of 
success you have had in communicating with your patient. A mark at the far left of the line 
would indicate no success at all, while a mark at the far right of the line would indicate very 
successful (i.e. no problems).
1. How well are you able to understand if your patient has any pain/discomfort?
No success                                                                               Very successful
                                                                                                                                                                      
2. How well are you able to get information from your patient about their previous 
medical history/allergies?
No success                                                                               Very successful
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3. How well are you able to assess presence of confusion and/or communication 
difficulties in your patient?
No success                                                                               Very successful
                                                                                                                                                                      
4. How well do you feel you understand the patient and their needs/wants/wishes?
No success                                                                               Very successful
                                                                                                                                                                      
For this question please think about the patient’s communication and indicate on the line 
how much is the patient’s communicative ability an obstacle for you in looking after them. 
A mark at the far left of the line would indicate that the patient’s communication is a big 
obstacle in cares, while a mark at the far right of the line would indicate that the patient’s 
communication is not an obstacle at all.
5. How big of an obstacle is the patient’s communicative ability for you in looking 
after them?
A big obstacle                                                                                  Not at all
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6. Any other comments?
Please also fill out the following details:
Age:
Gender:
Classification:      RN                CN                  other………………….
Years of experience:
Participant code (for the principal researcher to fill out): 
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Appendix 3
Quality of Health Communication in ICU Questionnaire - Patient
Participant No:                                                                                   Date:
Data Point:    pre-PMSV             PMSV insitu 
Length of PMSV use to-date:____________ (days)
Quality of Health Communication in ICU Questionnaire 
- Patient
To answer the following questions please think about the success of your communication 
attempts over __________________________ [researcher to indicate time]. 
Using the scale provided indicate through a mark on the line the level of success you have 
had with communication for each question. A mark at the far left of the line would indicate 
no success at all, while a mark at the far right of the line would indicate very successful 
(i.e. no problems).
No success                                                                               Very successful
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1. How successful are you in:
(a)  asking questions?
No success                                                                               Very successful
                                                                                                                                                                      
(b)  giving detailed information?
No success                                                                               Very successful
                                                                                                                                                           
(c) saying something quickly?
No success                                                                               Very successful
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2. Overall, how successful are you in getting your message across to the health 
care team?
No success                                                                               Very successful
                                                                                                                                                                           
3. Overall, how successful are you in getting your message across to family and 
friends?
No success                                                                               Very successful
                                                                                                                                                                           
To answer the following question you will also need to mark / indicate on the line your 
response, but in this case the far left end means not important at all and the far right 
means very important.
4. Overall how important is being able to communicate to others for you?
Not important                                                                              Very important
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Letter to the Editor
Patients want to be heard – loud and clear!
Anna-Liisa Sutt, John F Fraser 
Letter to the Editor; Critical Care 2017; 21:6
Accepted on 25th of Nov 2016
We congratulate Ten Hoorn et al on the systematic review of communication with ICU 
patients (1). Their work in defining an algorithm to assist improving communication options 
for these patients addresses a clear gap in patient-centred care in ICU. Despite the article 
giving a good overview of possible communication options for the ventilated ICU patient, 
we respectfully suggest that the most important communication option is the restoration of 
the patient’s own voice by enabling airflow through their larynx. This is particularly in the 
conscious patient cohort - the focus of the review article. We are supported by patient 
data, who have indicated that verbal communication is the most successful form of 
communication (2). Once tracheostomised, a speaking valve (SV) should be considered 
as the first option for communication – as it restores our natural way of communication. 
Beliefs that cuff deflation required for the restoration of laryngeal function with SV causes 
atelectasis or would be deleterious in the weaning process have been proven to be 
unfounded (3). There are currently lack of published data on safe ventilatory parameters 
for SV use. However, patients in our studies using a SV whilst mechanically ventilated, 
had substantial levels of PS and PEEP requirements, and were able to communicate using 
a SV in-line with their mechanical ventilation circuit successfully without any discernible 
harm to their respiratory function or weaning from the ventilator (3).
Using SVs is common in our cardio-thoracic ICU (4), may commence on day of 
tracheostomy insertion with patients spending hours, sometimes all awake hours being 
able to talk with the treating teams and loved ones. 
Following the success of this work, we now use SVs successfully with patients on VA 
ECMO, VADs and open chest. The difference it makes for the patients to have their own 
voice, and therefore be active participants in their care, is immeasurable with current tools. 
Studies elsewhere have also demonstrated benefits of early SV use in the ventilated 
tracheostomised ICU patient (5). Alternative communication options should be used only if 
natural communication is not able to be achieved or as complementary devices when 
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verbal communication is not fully successful. In the most critically ill, weakness frequently 
limits the use of AAC boards, and teaching complex new skills (i.e. electrolarynx) is fraught 
with difficulty. We concur with the importance of communication but suggest that before 
moving to more complex interventions, the larynx must always be considered. 
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